<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00274 Mid Day Module (Pathology-4) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 14819,
    "choices": [
      {
        "id": 59237,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Low fat diet</span></p>"
      },
      {
        "id": 59238,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">High protein diet</span></p>"
      },
      {
        "id": 59239,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Low gluten diet</span></p>"
      },
      {
        "id": 59240,
        "text": "<p><span style=\"font-size:12pt;\">Low calorie diet</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 12-year-old male presented with bloating of abdomen and steatorrhea. His HLA DQ2 was positive. Which of the following is the diet modification helping in the improvement of the condition of the patient?</span></p>",
    "unique_key": "Q4194383",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676712,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Low gluten diet</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Celiac disease </strong>is treated by <strong>removing gluten from the diet</strong>, which is found in <strong>wheat, barley, rye, and their derivatives</strong>. This prevents the<strong> immune response that damages the small intestine</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>A low-fat diet</strong> can be recommended for specific conditions such as <strong>pancreatitis or gallbladder disease, </strong>but <strong>celiac disease primarily </strong>requires the <strong>elimination of gluten from the diet</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B.&nbsp;While a balanced diet&nbsp;</strong>is important, the focus for<strong> treating celiac disease is on removing gluten</strong>, which is the<strong> trigger for the autoimmune response </strong>causing the symptoms.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Reducing calorie</strong> intake<strong> does not </strong>have a role in the management of<strong> celiac disease </strong>unless there are<strong> concurrent issues </strong>with <strong>obesity or metabolic syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>most effective dietary </strong>modification for a patient with<strong> celiac disease</strong>, suggested by the symptoms of<strong> malabsorption and a positive HLA DQ2, is a gluten-free diet.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> /e p784</strong></span></p>",
    "correct_choice_id": 59239,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14857,
    "choices": [
      {
        "id": 59388,
        "text": "<p><span style=\"font-size:12.0pt;\">Panacinar</span></p>"
      },
      {
        "id": 59389,
        "text": "<p><span style=\"font-size:12.0pt;\">Centriacinar</span></p>"
      },
      {
        "id": 59390,
        "text": "<p><span style=\"font-size:12.0pt;\">Paraseptal</span></p>"
      },
      {
        "id": 59391,
        "text": "<p><span style=\"font-size:12.0pt;\">Segmental</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 60-year-old patient with a history of smoking presents with progressive dyspnea and a chronic cough. Pulmonary function tests impaired expiratory flow. Chest imaging shows reveal hyperinflation. Which type of emphysema is most commonly associated with this clinical presentation?</span></p>",
    "unique_key": "Q2842417",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676678,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Centriacinar</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Centriacinar emphysema predominantly </strong>affects the<strong> central or proximal part of the acinus, </strong>sparing the <strong>peripheral parts</strong>. It is commonly associated with<strong> cigarette smoking. </strong>It has the<strong> maximum prevalence clinically</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Panacinar Emphysema:&nbsp;</strong>Panacinar emphysema involves the<strong> destruction of the entire respiratory acinus, </strong>including the <strong>respiratory bronchiole, alveolar ducts, and alveoli. </strong>It is often associated with <strong>alpha-1 antitrypsin deficiency.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Paraseptal Emphysema:&nbsp;</strong>Paraseptal emphysema, also known as <strong>distal acinar emphysema, </strong>involves the <strong>distal parts of the acinus</strong>, particularly the <strong>alveolar ducts and alveoli near the pleura</strong>. It often<strong> occurs adjacent to scars or fibrotic tissue</strong>, and it is associated with <strong>spontaneous pneumothorax.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Segmental Emphysema:&nbsp;</strong>Segmental emphysema refers to<strong> localized areas of emphysematous changes </strong>within a<strong> lung segment</strong>. It can occur in association with<strong> scarring or inflammation</strong>. While it is<strong> less common </strong>than other <strong>types of emphysema, </strong>it may contribute to<strong> localized airflow obstruction.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Centriacinar emphysema</strong>, is most commonly associated with<strong> cigarette smoking and predominantly </strong>affects the<strong> central parts of the acinus</strong>, leading to symptoms like<strong> progressive dyspnea and chronic cough in smokers</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 678)&nbsp;</strong></i></span></p>",
    "correct_choice_id": 59389,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14761,
    "choices": [
      {
        "id": 59005,
        "text": "<p><span style=\"font-size:12pt;\">1\u20132 days</span></p>"
      },
      {
        "id": 59006,
        "text": "<p><span style=\"font-size:12pt;\">3 weeks</span></p>"
      },
      {
        "id": 59007,
        "text": "<p><span style=\"font-size:12pt;\">6 hours</span></p>"
      },
      {
        "id": 59008,
        "text": "<p><span style=\"font-size:12pt;\">1 week</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The following is the hematoxylin and eosin stained section from the heart of a patient after myocardial infarction. What can you say about the age of the infarction?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/22/picture5.jpg\" alt=\"\" width=\"300\" height=\"198\"></span></p>",
    "unique_key": "Q6986173",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676693,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) 6 hours</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Presence of a coagulative necrotic pattern </strong>along with <strong>widened space between dead fibers </strong>and <i>wavy fiber </i>appearance sug\u00adgests this to a pattern of<strong> injury taking place around 6 hours.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The described appearance of <strong>coagulative necrosis</strong> with<strong> widened spaces between dead fibers and a wavy fiber appearance </strong>is characteristic of the changes seen approximately<strong> 6 hours after an infarction</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>At 1\u20132 days post-infarction, </strong>one would expect to see <strong>more infiltration by inflammatory cells</strong>,<strong> particularly neutrophils, and ongoing coagulative necrosis </strong>with<strong> loss of nuclei and striations, </strong>which is <strong>not </strong>the primary finding described.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>By 3 weeks, </strong>the <strong>necrotic area </strong>would likely be<strong> undergoing repair</strong>, with<strong> granulation tissue and new collagen deposition</strong>, which is<strong> not </strong>indicated by the <strong>presence of coagulative necrosis and wavy fibers.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>At 1 week</strong>, one would expect to see the <strong>beginnings of granulation tissue formation</strong>, which is<strong> not </strong>consistent with the<strong> early necrotic pattern </strong>described in the <strong>vignette.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A <strong>coagulative necrotic pattern </strong>with <strong>widened spaces between dead fibers and wavy fiber </strong>appearance on a histological section of <strong>myocardium </strong>is suggestive of a <strong>myocardial injury </strong>that occurred around <strong>6 hours prior</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histological Features of MI by Time Frame:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8PpfDsx.png\" width=\"1489\" height=\"439\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 548)</strong></span></p>",
    "correct_choice_id": 59007,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14853,
    "choices": [
      {
        "id": 59372,
        "text": "<p><span style=\"font-size:12.0pt;\">Bronchiectasis</span></p>"
      },
      {
        "id": 59373,
        "text": "<p><span style=\"font-size:12.0pt;\">Bronchial asthma</span></p>"
      },
      {
        "id": 59374,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic bronchitis</span></p>"
      },
      {
        "id": 59375,
        "text": "<p><span style=\"font-size:12.0pt;\">Emphysema</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 50-year-old man with a history of chronic cough and sputum production presents to the clinic. Pulmonary function tests reveal airway obstruction with a reduced FEV1/FVC ratio. He reports a smoking history of 30 pack-years. Which of the following conditions is most likely contributing to an increased Reid's index in this patient?</span></p>",
    "unique_key": "Q1737692",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676675,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Chronic bronchitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Reid's index </strong>is a measure of the ratio of the<strong> thickness of the submucosal glands </strong>to the <strong>thickness of the bronchial wall</strong>. It is used to assess <strong>hypertrophy of submucosal glands </strong>in bronchi.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Chronic bronchitis:</strong> Chronic bronchitis is associated with <strong>increased mucus production and inflammation. </strong>It can lead to an <strong>increased Reid's index </strong>due to <strong>hypertrophy of submucosal glands</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Bronchiectasis:&nbsp;</strong>In bronchiectasis, there is<strong> irreversible dilation of the bronchi</strong>. Reid's index is typically <strong>not a prominent </strong>feature in bronchiectasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B: Bronchial asthma:</strong> Asthma is characterized by<strong> reversible bronchoconstriction and inflammation</strong>. Reid's index is usually not significantly increased in bronchial asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: Emphysema:</strong> Emphysema is characterized by the<strong> destruction of alveolar walls</strong>, leading to<strong> airspace enlargement</strong>. Reid's index is not a characteristic feature of emphysema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Reid's index </strong>is a measure of the ratio of the<strong> thickness of the submucosal glands to the thickness of the bronchial wall </strong>that is a characteristic of <strong>chronic bronchitis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal value: &lt; 0.4</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In chronic bronchitis: &gt; 0.5 due to hypertrophy and hyperplasia of mucous glands</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 681)</strong></span></p>",
    "correct_choice_id": 59374,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14760,
    "choices": [
      {
        "id": 59001,
        "text": "<p><span style=\"font-size:12.0pt;\">Blue</span></p>"
      },
      {
        "id": 59002,
        "text": "<p><span style=\"font-size:12.0pt;\">White</span></p>"
      },
      {
        "id": 59003,
        "text": "<p><span style=\"font-size:12.0pt;\">Yellow</span></p>"
      },
      {
        "id": 59004,
        "text": "<p><span style=\"font-size:12pt;\">Brick red</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">During autopsy of a patient died due to suspected myocardial infarction, the heart was stained with triphenyl tetrazolium tetra-chloride dye. What will be the color of the viable myocardium?</span></p>",
    "unique_key": "Q5433311",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676692,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Brick red&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/22/picture4.jpg\" alt=\"\" width=\"1000\" height=\"342\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This is the correct answer.<strong> Brick red </strong>coloration indicates <strong>viable myocardium </strong>when using <strong>TTC staining. </strong>Intact,<strong> noninfarcted myocardium </strong>contains enzymes like<strong> lactate dehydrogenase </strong>that reduce <strong>TTC to formazan, </strong>which has a <strong>brick-red color</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Blue is not </strong>the color associated with <strong>TTC staining</strong>. TTC is not a blue dye and does not produce a blue color in tissue staining.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;White </strong>is the color that indicates an i<strong>nfarct on TTC staining </strong>because the <strong>enzyme activity </strong>necessary to convert <strong>TTC into a red dye </strong>is <strong>lost </strong>in the infarcted area <strong>due to cell death</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Yellow </strong>is <strong>not </strong>a typical result of<strong> TTC staining </strong>in either<strong> viable or non-viable myocardial tissue.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>TTC staining </strong>during <strong>autopsy, viable myocardium</strong> is indicated by a<strong> brick-red color,</strong> which results from the <strong>presence of active dehydrogenase enzymes </strong>that <strong>reduce the TTC dye</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup> 546)</strong></i></span></p>",
    "correct_choice_id": 59004,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14839,
    "choices": [
      {
        "id": 59316,
        "text": "<p><span style=\"font-size:12pt;\">Presence of interstitial inflammation</span></p>"
      },
      {
        "id": 59317,
        "text": "<p><span style=\"font-size:12pt;\">Predominance of alveolar exudate</span></p>"
      },
      {
        "id": 59318,
        "text": "<p><span style=\"font-size:12pt;\">Bronchiolitis</span></p>"
      },
      {
        "id": 59319,
        "text": "<p><span style=\"font-size:12pt;\">Multinucleate giant cells in the bronchiolar wall</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">All of the following features are seen in the viral pneumonia except:</span></p>",
    "unique_key": "Q6591704",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676718,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Predominance of alveolar exudate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Predominance of alveolar exudate:</strong> Alveolar exudate is characteristic of <strong>bacterial pneumonia</strong>, where the<strong> alveoli are filled with fluid and inflammatory cells</strong>. This feature is <strong>less common in viral pneumonia, </strong>which tends to involve the<strong> interstitium and bronchioles more </strong>than the <strong>alveoli.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Presence of interstitial inflammation:</strong> This is a<strong> common feature </strong>in <strong>viral pneumonia</strong>, where the infection leads to <strong>inflammation predominantly </strong>in the <strong>tissue and space around the air sacs of the lungs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Bronchiolitis:</strong> Bronchiolitis, which is<strong> inflammation of the small airways or bronchioles, </strong>is commonly seen in<strong> viral pneumonia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Multinucleate giant cells in the bronchiolar wall:</strong> The presence of multinucleate giant cells is a<strong> histopathological feature </strong>sometimes seen in<strong> viral infections, </strong>reflecting the body's response to<strong> viral replication within cells</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The<strong> predominance of alveolar exudate </strong>is<strong> not </strong>a feature commonly seen in<strong> viral pneumonia; </strong>instead, it is a <strong>hallmark of bacterial pneumonia</strong>. <strong>Viral pneumonia </strong>typically presents with <strong>interstitial inflammation, bronchiolitis</strong>, and can have <strong>multinucleate giant cells </strong>in the bronchiolar wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histopathological Features of Viral Pneumonia:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Luhw4oK.png\" width=\"1281\" height=\"502\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 708)</strong></span></p>",
    "correct_choice_id": 59317,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14782,
    "choices": [
      {
        "id": 59089,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Crohn\u2019s disease</span></p>"
      },
      {
        "id": 59090,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Ulcerative colitis</span></p>"
      },
      {
        "id": 59091,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Colonic carcinoma</span></p>"
      },
      {
        "id": 59092,
        "text": "<p><span style=\"font-size:12pt;\">Ileal polyp</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">A 25-year-old patient with a history of chronic bloody diarrhea undergoes a colonoscopy. The procedure reveals continuous colonic mucosal inflammation extending proximally from the rectum to the cecum, and notable inflammation of the terminal ileum. </span><span style=\"font-size:12.0pt;\">Backwash ileitis is seen in:</span></p>",
    "unique_key": "Q2226841",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676701,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Ulcerative colitis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Ulcerative colitis </strong>commonly presents with <strong>continuous colonic inflammation </strong>that may extend <strong>proximally in a continuous fashion from the rectum. </strong>When it involves the <strong>terminal ileum</strong>, this is referred to as <strong>backwash ileitis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>Crohn's disease</strong> is characterized by <strong>patchy, \"skip\" areas of inflammation, </strong>which can involve any part of the <strong>GI tract from the mouth to the anus</strong>. While <strong>ileal </strong>involvement is <strong>common in Crohn's</strong>, the <strong>continuous inflammation pattern </strong>described <strong>does not typically occur</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C.&nbsp;Colonic carcinoma&nbsp;</strong>may lead to <strong>secondary inflammation </strong>due to <strong>obstruction or invasion </strong>but <strong>does not cause backwash ileitis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Ileal polyps</strong> may be a feature of <strong>various polyposis syndromes </strong>but are<strong> not </strong>associated with <strong>backwash ileitis</strong>, which is specifically related to<strong> inflammatory bowel disease</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Backwash ileitis </strong>refers to the <strong>extension of inflammatory changes from the colon into the terminal ileum </strong>and is associated with <strong>ulcerative colitis</strong>, not Crohn's disease, colonic carcinoma, or ileal polyps.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>:&nbsp;Robbins 10<sup>th</sup>/ 801</strong></span></p>",
    "correct_choice_id": 59090,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14706,
    "choices": [
      {
        "id": 58785,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Temporal arteritis </span></span></p>"
      },
      {
        "id": 58786,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wegener&rsquo;s granulomatosis </span></span></p>"
      },
      {
        "id": 58787,
        "text": "<p><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyarteritis nodosa </span></span></p>"
      },
      {
        "id": 58788,
        "text": "<p><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Henoch\u2011Sch&ouml;nlein purpura </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is associated with vasculitis of medium size vessels? </span></span></span></p>",
    "unique_key": "Q7500241",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676717,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Polyarteritis nodosa </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Polyarteritis nodosa</strong> (PAN) is associated with <strong>vasculitis of medium-sized vessels.</strong> It is a <strong>systemic necrotizing vasculitis </strong>that affects <strong>medium-sized arteries,</strong> leading to <strong>inflammation, damage,</strong> and potential <strong>organ dysfunction.</strong> <strong>PAN</strong> can involve <strong>various organs</strong>, including the <strong>kidneys, heart, gastrointestinal tract,</strong> and <strong>nerves</strong>, due to the widespread nature of <strong>medium-sized artery inflammation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Temporal arteritis,</strong> also known as <strong>giant cell arteritis,</strong> primarily involves <strong>large and medium-sized arteries.</strong> It commonly affects the temporal arteries.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Wegener&#39;s granulomatosis</strong> (now known as Granulomatosis with Polyangiitis or GPA) involves <strong>small to medium-sized vessels,</strong> affecting the <strong>respiratory tract</strong> (nose, sinuses, and lungs) and sometimes the <strong>kidneys.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Henoch-Sch&ouml;nlein purpura</strong> typically involves <strong>small vessels,</strong> such as <strong>capillaries and arterioles.</strong> It is characterized by <strong>immune-mediated inflammation of blood vessels</strong>, leading to symptoms like <strong>palpable purpura</strong>, <strong>joint pain, and abdominal pain</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Polyarteritis nodosa </strong>(PAN) is associated with <strong>vasculitis of medium-sized vessels </strong>associated with <strong>hepatitis B infection.</strong>&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 513)</span></em></strong></span></span></p>",
    "correct_choice_id": 58787,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14677,
    "choices": [
      {
        "id": 58669,
        "text": "<p><span style=\"font-size:12pt;\">Takayasu arteritis</span></p>"
      },
      {
        "id": 58670,
        "text": "<p><span style=\"font-size:12pt;\">Giant cell arteritis</span></p>"
      },
      {
        "id": 58671,
        "text": "<p><span style=\"font-size:12pt;\">Microscopic polyangiitis</span></p>"
      },
      {
        "id": 58672,
        "text": "<p><span style=\"font-size:12pt;\">Temporal arteritis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 35-year-old patient comes to the clinic with concerns of difficulty in using her right arm, especially when performing tasks like combing her hair or reaching for objects on high shelves. She also reports occasional dizziness and headaches. On examination, you notice a significant difference in blood pressure between her arms, with the right arm showing a considerably lower reading. Additionally, the patient's right radial pulse is weak compared to the left. Fundoscopic examination reveals retinal hemorrhages. Which of the following is the most likely diagnosis?</span></p>",
    "unique_key": "Q4429918",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676708,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Takayasu arteritis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Takayasu arteritis </strong>is a <strong>granulomatous vasculitis of medium- and large-sized arteries </strong>particularly affecting the<strong> aorta and its main branches. </strong>This condition is more common in<strong> young women</strong>. Its clinical features may include <strong>diminished or absent pulses</strong>, particularly in the <strong>upper extremities</strong>. This is due to<strong> inflammation and stenosis of the large vessels</strong>, leading to <strong>reduced blood flow</strong>. <strong>Ocular </strong>involvement, including <strong>retinal hemorrhages</strong>, can be a manifestation of <strong>Takayasu arteritis</strong>. The<strong> inflammation and narrowing </strong>of the vessels can affect<strong> blood flow to various organs</strong>, including the <strong>eyes</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Takayasu arteritis </strong>is a characterized princi\u00adpally by <strong>ocular disturbances </strong>and <strong>marked weakening of the pulses </strong>in the upper extremities (hence the alternate name, pulseless disease)\u2026Robbins</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Giant cell arteritis</strong> typically affects <strong>older individuals</strong> and involves <strong>inflammation of medium to large-sized arteries</strong>. It commonly presents with <strong>headaches, jaw claudication, </strong>and<strong> visual disturbances</strong> but is<strong> less </strong>associated with<strong> reduced pulses</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Microscopic polyangiitis </strong>is a <strong>small-vessel vasculitis</strong>. It often presents with <strong>renal involvement, lung disease, and skin manifestations</strong>. It is less likely to cause the characteristic findings of <strong>reduced pulses and retinal hemorrhages </strong>seen in the scenario.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong>&nbsp;<strong>Temporal arteritis</strong>, also known as<strong> giant cell arteritis </strong>when involving <strong>large vessels</strong>, is characterized by<strong> inflammation of medium to large arteries. </strong>While it can affect the<strong> upper limb arteries</strong>, it is more closely associated with the<strong> temporal arteries and </strong>often presents with<strong> headaches, jaw claudication, and visual disturbances.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The clinical features of <strong>Takayasu arteritis </strong>includes<strong> reduced pulses in the upper limbs and retinal hemorrhages.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup> 385)</strong></span></p>",
    "correct_choice_id": 58669,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14775,
    "choices": [
      {
        "id": 59061,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Autosomal recessive inheritance</span></p>"
      },
      {
        "id": 59062,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Screening done by sigmoidoscopy</span></p>"
      },
      {
        "id": 59063,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Polyps develop in early adulthood</span></p>"
      },
      {
        "id": 59064,
        "text": "<p><span style=\"font-size:12pt;\">Epidermal cysts and osteomas may occur</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:#0d0d0d;font-size:12.0pt;\">In the clinical evaluation of a patient with a strong family history of colorectal cancer, which of the following characteristics is not consistent with familial adenomatous polyposis (FAP)?</span></p>",
    "unique_key": "Q4894558",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676700,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Autosomal recessive inheritance</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>FAP is an autosomal dominant </strong>condition</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Familial polyposis syndrome (FAP) is an <strong>autosomal domi\u00adnant</strong> disorder.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It is caused by<strong> mutation in the adeno\u00admatous polyposis coli or APC gene on chromosome 5q21</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A<strong>t least 100 polyps </strong>are necessary for a diagnosis of FAP.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Since <strong>colorectal carci\u00adnoma develop in 100% of untreated FAP </strong>patients often <strong>before age 30</strong>, so,<strong> prophylactic colectomy is the standard therapy </strong>in patients with APC mutations.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B.&nbsp;Screening </strong>for polyps in individuals with<strong> FAP or at risk of FAP </strong>is typically performed with <strong>sigmoidoscopy or colonoscopy</strong>, as <strong>polyps </strong>tend to occur throughout the colon.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C.&nbsp;Polyp </strong>development in FAP usually <strong>starts in the teenage years </strong>or <strong>early adulthood </strong>and if<strong> left untreated</strong>, these polyps can lead to <strong>colorectal cancer, </strong>often before the age of 30.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.&nbsp;Associated features of FAP </strong>may include various extracolonic manifestations, including <strong>epidermal cysts, osteomas, and other benign growths</strong>, which are<strong> true.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Familial adenomatous polyposis (FAP) </strong>is an <strong>autosomal dominant disorder</strong>, not an autosomal recessive condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 812</strong></span></p>",
    "correct_choice_id": 59061,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14850,
    "choices": [
      {
        "id": 59360,
        "text": "<p><span style=\"font-size:12.0pt;\">Caseation</span></p>"
      },
      {
        "id": 59361,
        "text": "<p><span style=\"font-size:12pt;\">Recruitment of lymphocytes</span></p>"
      },
      {
        "id": 59362,
        "text": "<p><span style=\"font-size:12pt;\">Formation of giant cells (Langhans)</span></p>"
      },
      {
        "id": 59363,
        "text": "<p><span style=\"font-size:12pt;\">Granuloma formation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 35-year-old woman presents with a persistent cough, night sweats, and unintentional weight loss. Chest X-ray reveals an infiltrate in the upper lobe of the right lung. Which of the following is the earliest feature of tuberculosis?</span></p>",
    "unique_key": "Q9112635",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676673,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Recruitment of lymphocytes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Recruitment of lymphocytes:</strong> The<strong> initial immune </strong>response to<strong> M. tuberculosis </strong>includes <strong>recruitment of lymphocytes </strong>to the site of <strong>infection.</strong> This is part of the <strong>early host defense</strong>, which precedes<strong> granuloma formation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Caseation:</strong> Caseation, a form of <strong>necrosis typical of tuberculosis</strong>, is a later feature that occurs after the <strong>immune system </strong>has attempted to <strong>contain the infection</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C: Formation of giant cells (Langhans):</strong> Giant cell formation is part of the<strong> granuloma </strong>response and occurs after <strong>lymphocyte recruitment</strong>, as part of the body's attempt to wall off and contain the infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: Granuloma formation:</strong> Granuloma formation is a<strong> hallmark of the body's defense against tuberculosis </strong>but is <strong>not </strong>the <strong>earliest</strong> event. It occurs after<strong> lymphocytes and macrophages </strong>have been recruited to the site of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Recruitment of lymphocytes </strong>is the earliest feature in the<strong> immune response </strong>to <strong>M. tuberculosis infection</strong>. Following<strong> infection, lymphocytes are recruited, </strong>leading to the<strong> activation of macrophages and subsequent granuloma formation</strong>.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 378)</strong></i></span></p>",
    "correct_choice_id": 59361,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14701,
    "choices": [
      {
        "id": 58765,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skin and nose </span></span></p>"
      },
      {
        "id": 58766,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lung and kidney </span></span></p>"
      },
      {
        "id": 58767,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart and kidney </span></span></p>"
      },
      {
        "id": 58768,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kidney and nervous system </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common organs involved in Wegener&rsquo;s granulo&shy;matosis are: </span></span></span></p>",
    "unique_key": "Q1329470",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676714,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Lung and kidney </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wegener&#39;s granulomatosis</strong>, now known as <strong>Granulomatosis with Polyangiitis </strong>(GPA), is characterized by <strong>necrotizing granulomatous inflammation </strong>affecting the <strong>respiratory tract </strong>(nose, sinuses, and lungs) and <strong>often the kidneys</strong>. It is associated with <strong>PR3-ANCA positivity</strong>, specifically against proteinase 3. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most <strong>common organs </strong>involved in <strong>Wegener&rsquo;s granulo&shy;matosis </strong>are <strong>lung and kidney</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 514) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
    "correct_choice_id": 58766,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14680,
    "choices": [
      {
        "id": 58681,
        "text": "<p><span style=\"font-size:12.0pt;\">Atherosclerosis</span></p>"
      },
      {
        "id": 58682,
        "text": "<p><span style=\"font-size:12.0pt;\">Syphilis</span></p>"
      },
      {
        "id": 58683,
        "text": "<p><span style=\"font-size:12.0pt;\">Trauma</span></p>"
      },
      {
        "id": 58684,
        "text": "<p><span style=\"font-size:12.0pt;\">Congenital</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 65-year-old male smoker with a history of hypertension presents with mild abdominal discomfort and is found to have a pulsatile mass on abdominal examination. His blood pressure is well-controlled on antihypertensive medication. Which of the following is the most common cause of abdominal aortic aneurysm?&nbsp;</span></p>",
    "unique_key": "Q9234281",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676709,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Atherosclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Direct quote from Harrison\u2026.\u2019<strong>atleast 90% of all abdominal aortic aneurysms &gt;4.0 cm are related to atherosclerotic disease and most are present just below the renal arteries\u2019</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>predominant </strong>cause of <strong>AAA&nbsp; </strong>is <strong>atherosclerosis, </strong>a condition characterized by the <strong>build-up of fatty deposits, cholesterol,</strong> and other <strong>substances on the walls of arteries.</strong> Over time, this leads to the formation of <strong>plaques </strong>that can<strong> weaken and damage the arterial walls.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;</strong>While <strong>syphilis </strong>can cause <strong>aortic aneurysms</strong>, it is<strong> less common </strong>in contemporary medicine due to the widespread use of <strong>antibiotics. </strong>Atherosclerosis is a more prevalent and frequent cause.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Trauma </strong>can indeed lead to <strong>aortic aneurysms</strong>, but it's generally <strong>less common </strong>than <strong>atherosclerosis </strong>as a cause. <strong>Traumatic aneurysms </strong>often result from <strong>severe injuries or accidents</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong>&nbsp;<strong>Congenital factors </strong>can contribute to the development of <strong>aortic aneurysms</strong>, but they are <strong>less </strong>common compared to <strong>acquired conditions</strong>. <strong>Atherosclerosis </strong>is still a <strong>more prevalent</strong> cause in the <strong>adult population.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> predominant </strong>cause of <strong>abdominal aortic aneurysm is atherosclerosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 509)</strong></span></p>",
    "correct_choice_id": 58681,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14739,
    "choices": [
      {
        "id": 58917,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Wheat</span></p>"
      },
      {
        "id": 58918,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Barley</span></p>"
      },
      {
        "id": 58919,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Maize</span></p>"
      },
      {
        "id": 58920,
        "text": "<p><span style=\"font-size:12pt;\">Rye</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The following cereals should be avoided in patients with celiac diseases, except:</span></p>",
    "unique_key": "Q6463463",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676681,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Maize (Ref: Robbins 10<sup>th</sup> /785)</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">It is a disease characterized by <strong>increased sensitivity to a protein called gliadin </strong>present in the grains lik<strong>e wheat; oat, barley and rye </strong>resulting in a <strong>T-cell me\u00addiated chronic inflammatory reaction </strong>in the small intestine and<strong> impaired absorption</strong>. It is associated with <strong>HLA-DQ2 or HLA-DQ8.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">In<strong> celiac disease</strong>, the consumption of grains <strong>containing gluten </strong>should be avoided. <strong>Gluten is a protein found </strong>in:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Wheat</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Barley</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Rye</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> /785</strong></span></p>",
    "correct_choice_id": 58919,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14844,
    "choices": [
      {
        "id": 59336,
        "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
      },
      {
        "id": 59337,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">2-3</span></p>"
      },
      {
        "id": 59338,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">3-4</span></p>"
      },
      {
        "id": 59339,
        "text": "<p><span style=\"font-size:12.0pt;\">5-7</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Gray hepatization of lungs is seen on which days:</span></p>",
    "unique_key": "Q3874499",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676721,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. 5-7</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the stages of bacterial pneumonia:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Congestion (Day 1-2):</strong> The affected lobe becomes<strong> heavy and hyperemic due to increased blood flow</strong>. The alveoli are filled with<strong> organisms, fibrin, and bacteria.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Red Hepatization (Day 2-4):</strong> The lung appears<strong> red and firm </strong>due to continued<strong> congestion</strong>. There is an <strong>influx of red blood cells (RBCs) and fibrin into the alveoli</strong>, leading to a<strong> solid, liver-like consistency.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Gray Hepatization (Day 4-7):</strong> The <strong>red color fades</strong>, and the lung becomes<strong> gray-brown</strong>. This stage is characterized by <strong>ongoing inflammation, presence of fibrinopurulent exudate</strong>, and persistence of<strong> inflammatory cells</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Resolution (beyond day 7):</strong> The<strong> inflammation </strong>gradually <strong>subsides, </strong>and <strong>macrophages clear the debris </strong>from the alveoli. The lung returns to<strong> normal architecture.</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Gray hepatization of lungs </strong>is seen on <strong>day 5-7 of bacterial pneumonia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><i><strong>(Ref: Harsh Mohan 6/e p469)</strong></i></span></p>",
    "correct_choice_id": 59339,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14742,
    "choices": [
      {
        "id": 58929,
        "text": "<p><span style=\"font-size:12pt;\">C- reactive protein</span></p>"
      },
      {
        "id": 58930,
        "text": "<p><span style=\"font-size:12pt;\">Anti- proteinase 3</span></p>"
      },
      {
        "id": 58931,
        "text": "<p><span style=\"font-size:12pt;\">Cryoglobulin</span></p>"
      },
      {
        "id": 58932,
        "text": "<p><span style=\"font-size:12pt;\">Platelet count</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which laboratory test parameter can indicate the highest relative risk for developing atherosclerosis?</span></p>",
    "unique_key": "Q3430486",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676684,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) C- reactive protein</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>C-reactive protein (CRP)</strong> is an <strong>inflammatory marker </strong>that when<strong> elevated</strong>, indicates<strong> endothelial cell activation </strong>and is associated with the development of<strong> atherosclerosis and cardiovascular risk.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>C- reactive protein (CRP) </strong>is an <strong>acute phase reactant </strong>that causes <strong>endothelial cell activation, </strong>promote <strong>thrombosis and increases leukocyte adhesiveness </strong>in developing <strong>atheromas.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It is an<strong> independent predictor </strong>of CV risk.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Anti-proteinase 3 (PR3)</strong> is an <strong>antibody </strong>associated with<strong> vasculitis</strong>, specifically <strong>granulomatosis with polyangiitis</strong>, and is <strong>not </strong>a direct marker for <strong>atherosclerosis risk.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Cryoglobulins</strong> are<strong> immunoglobulins </strong>that precipitate in the <strong>cold </strong>and are associated with <strong>cryoglobulinemic vasculitis </strong>but are not direct indicators of atherosclerotic risk.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Platelet count</strong> can reflect<strong> thrombotic risk </strong>but is<strong> not an independent predictor of atherosclerosis or cardiovascular disease</strong> like<strong> CRP.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>CRP </strong>is an <strong>acute-phase reactant </strong>that, when <strong>elevated</strong>, suggests <strong>systemic inflammation </strong>and is an <strong>independent risk factor </strong>for <strong>atherosclerosis and subsequent cardiovascular events</strong>.</span></p>",
    "correct_choice_id": 58929,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14744,
    "choices": [
      {
        "id": 58937,
        "text": "<p><span style=\"font-size:12.0pt;\">Pancarditis</span></p>"
      },
      {
        "id": 58938,
        "text": "<p><span style=\"font-size:12.0pt;\">Arthritis</span></p>"
      },
      {
        "id": 58939,
        "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous nodules</span></p>"
      },
      {
        "id": 58940,
        "text": "<p><span style=\"font-size:12.0pt;\">Elevated ESR</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which one of the following is not included as major criteria in Jones criteria?</span></p>",
    "unique_key": "Q1892531",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676686,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Elevated ESR</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> Jones </strong>criteria are used for the diagnosis of<strong> rheumatic fever</strong>. The major criteria include:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Pancarditis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Arthritis</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Subcutaneous nodules</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Sydenham chorea</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Erythema marginatum&nbsp;</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Elevated ESR (Erythrocyte Sedimentation Rate) </strong>is <strong>not </strong>a <strong>major criterion </strong>in the Jones criteria. While it can support the <strong>diagnosis of rheumatic fever </strong>as it indicates<strong> inflammation, </strong>it is <strong>not specific </strong>and is considered a minor criterion.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Pancarditis </strong>is a major criterion in the <strong>Jones criteria</strong>. It encompasses <strong>inflammation of the entire heart</strong>, including the <strong>endocardium, myocardium, and pericardium.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> Arthritis, specifically<strong> migratory polyarthritis, </strong>is a <strong>major criterion </strong>of the <strong>Jones criteria</strong>, typically affecting <strong>large joints.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Subcutaneous nodules</strong> are also a <strong>major criterion</strong> in the <strong>Jones criteria</strong>, though they are<strong> less common. </strong>They are <strong>firm,</strong> <strong>painless, and found over bones or tendons.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> Jones criteria</strong> for the <strong>diagnosis of rheumatic fever </strong>include major criteria such as <strong>pancarditis, arthritis, subcutaneous nodules</strong>, <strong>Sydenham chorea, and erythema marginatum. Elevated ESR</strong>, while indicative of <strong>inflammation, </strong>is <strong>not</strong> a major criterion and is <strong>used</strong> as a <strong>minor or supportive criterion</strong> in the <strong>diagnosis of rheumatic fever.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 562)</strong></i></span></p>",
    "correct_choice_id": 58940,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14728,
    "choices": [
      {
        "id": 58873,
        "text": "<p><span style=\"font-size:12.0pt;\">Rash</span></p>"
      },
      {
        "id": 58874,
        "text": "<p><span style=\"font-size:12.0pt;\">Lymph node</span></p>"
      },
      {
        "id": 58875,
        "text": "<p><span style=\"font-size:12.0pt;\">Cardiac involvement</span></p>"
      },
      {
        "id": 58876,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombrocytosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 3-year-old boy presents with high fever for five days, bilateral nonexudative conjunctivitis, red cracked lips, a strawberry tongue, and swelling of the hands and feet. The child appears irritable, and his mother mentions a rash that developed over his trunk and extremities. Most dreadful complication of Kawasaki\u2019s disease is:</span></p>",
    "unique_key": "Q4937355",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676679,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Cardiac involvement</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Kawasaki disease,</strong>&nbsp;It is a<strong> systemic vasculitis </strong>that primarily affects <strong>children</strong>. The classic features include <strong>prolonged fever</strong>, <strong>mucocutaneous involvement (such as the strawberry tongue and erythematous rash), and cervical lymphadenopathy</strong>. If<strong> untreated, </strong>Kawasaki disease can lead to <strong>coronary artery involvement </strong>and potentially <strong>serious complications</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cardiac involvement, specifically<strong> coronary artery aneurysms</strong>, is the<strong> most </strong>severe complication of <strong>Kawasaki disease </strong>and can have <strong>long-term cardiovascular implications</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong> While<strong> rash </strong>is a common feature of<strong> Kawasaki disease</strong>, it is <strong>not </strong>typically associated with the most serious complications.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Lymph node enlargement </strong>can be a feature of <strong>Kawasaki disease </strong>but is not considered the most severe complication.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Thrombocytosis </strong>is common in the<strong> second week </strong>of illness in<strong> Kawasaki disease </strong>and typically resolves; it is<strong> not </strong>the most feared complication.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">When treating <strong>Kawasaki disease</strong>, <strong>close monitoring </strong>for cardiac complications, such as <strong>coronary artery aneurysms</strong>, is critical due to the risk of <strong>serious outcomes like myocardial infarction or sudden death</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Robbins 10<sup>th</sup> 512)</strong></i></span></p>",
    "correct_choice_id": 58875,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14674,
    "choices": [
      {
        "id": 58657,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MI</span></span></p>"
      },
      {
        "id": 58658,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stroke</span></span></p>"
      },
      {
        "id": 58659,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lower limb ischemia </span></span></p>"
      },
      {
        "id": 58660,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vertebrobasilar insufficiency </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In 2 patients with atherosclerosis, one is diabetic and the other is non diabetic. In relation to the non diabetic, the diabetic patient has 100 times risk of which of the following?</span></span></span></p>",
    "unique_key": "Q5725195",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676706,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Lower limb ischemia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The quote from Robbins indicates that<strong> diabetic individuals </strong>have a risk of <strong>lower limb ischemia </strong>approximately<strong> 100 times higher than </strong>that of the <strong>general population</strong>. <strong>Peripheral arterial disease</strong> leading to <strong>lower limb ischemia</strong> is a well-known complication of <strong>diabetes</strong> due to <strong>advanced vascular disease.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct quote from Robbins... <em><strong>&lsquo;Gangrene of the lower extrem&shy;ities</strong> as a result of <strong>advanced vascular disease</strong> is about <strong>100</strong> <strong>times more </strong>common in<strong> diabetics </strong>than in general population&rsquo;.</em></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> risk of myocardial infarction (MI) </strong>is <strong>twice </strong>in a <strong>diabetic </strong>as compared to a <strong>non diabetic individual.</strong></span></em></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Diabetic individuals</strong> have approximately <strong>twice the risk of myocardial infarction (MI)</strong> compared to non-diabetics. While diabetes is a significant risk factor for MI, the relative risk is not as high as 100 times compared to the general population.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Diabetes</strong> is a major risk factor for <strong>stroke, </strong>but the <strong>relative risk of stroke in diabetic individuals </strong>compared to non-diabetics is not typically cited as 100 times higher. The risk may be elevated, but not to the extent described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>diabetes </strong>is associated with an<strong> increased risk of cerebrovascular disease</strong>, including <strong>vertebrobasilar insufficiency</strong>, the relative risk compared to non-diabetics is not typically stated as 100 times higher.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gangrene of the lower extrem&shy;ities </strong>as a result of <strong>advanced vascular disease </strong>is about <strong>100 times more common in diabetics </strong>than in general population.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 1145)</span></em></strong></span></span></p>",
    "correct_choice_id": 58659,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14746,
    "choices": [
      {
        "id": 58945,
        "text": "<p><span style=\"font-size:12pt;\">Infective endocarditis</span></p>"
      },
      {
        "id": 58946,
        "text": "<p><span style=\"font-size:12pt;\">Libman Sacks endocarditis</span></p>"
      },
      {
        "id": 58947,
        "text": "<p><span style=\"font-size:12pt;\">Rheumatic heart disease</span></p>"
      },
      {
        "id": 58948,
        "text": "<p><span style=\"font-size:12pt;\">Rheumatoid heart disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Most friable vegetation is seen in:</span></p>",
    "unique_key": "Q3294443",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676688,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Infective endocarditis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/20/picture2.jpg\" alt=\"\" width=\"1000\" height=\"547\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most <strong>friable vegetations</strong>, which are indicative of a<strong> high risk of embolization</strong>, are seen in<strong> infective endocarditis</strong><i><strong>.</strong></i></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Friability refers to how easily a lesion breaks apart or embolizes. In cardiac vegetations, infective endocarditis (IE) is known to produce the most friable vegetations, due to their soft, necrotic, and loosely attached nature.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_I40O1Mu.png\" width=\"1016\" height=\"500\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 563)</strong></span></p>",
    "correct_choice_id": 58945,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14702,
    "choices": [
      {
        "id": 58769,
        "text": "<p><span style=\"font-size:12pt;\">Pulmonary artery</span></p>"
      },
      {
        "id": 58770,
        "text": "<p><span style=\"font-size:12pt;\">Bronchial artery</span></p>"
      },
      {
        "id": 58771,
        "text": "<p><span style=\"font-size:12pt;\">Renal artery</span></p>"
      },
      {
        "id": 58772,
        "text": "<p><span style=\"font-size:12pt;\">Cerebral artery</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 45-year-old woman with severe hypertension and worsening renal function is evaluated for suspected systemic vasculitis. She has a history of intermittent claudication and abdominal pain following meals. A biopsy of a medium-sized artery in her leg shows transmural inflammation with fibrinoid necrosis. Based on her clinical presentation, Polyarteritis nodosa does not involve:</span></p>",
    "unique_key": "Q6908199",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676715,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Pulmonary artery</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Polyarteritis nodosa</strong> typically does <strong>not</strong> involve the <strong>pulmonary arteries.</strong> It tends to <strong>affect arteries</strong> supplying various <strong>organs and tissues</strong>, but the <strong>pulmonary arteries</strong> are not commonly affected.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Although large and muscular, pulmonary arteries are part of the pulmonary circulation, which is a low-pressure system distinct from the systemic arteries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PAN is strictly a systemic vasculitis, the pulmonary arteries are consistently uninvolved. </span><span style=\"font-size:12pt;\">Therefore, option (a) is correct.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Polyarteritis nodosa</strong> can involve <strong>bronchial arteries</strong>. In fact, it can affect arteries throughout the body, including those supplying the respiratory system.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong> <strong>Polyarteritis nodosa</strong> commonly involves the <strong>renal arteries.</strong> Renal artery involvement can lead to renal ischemia and glomerulonephritis, which are characteristic features of PAN.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong> <strong>Polyarteritis nodosa</strong> typically does not commonly involve <strong>cerebral arteries.</strong> However, the best answer in the given question is pulmonary artery.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>polyarteritis nodosa</strong>, the <strong>pulmonary arteries </strong>are typically <strong>spared</strong>, which <strong>helps differentiate </strong>it from other <strong>systemic vasculitides</strong> that can involve the<strong> lungs</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup> / 513)&nbsp;</strong></span></p>",
    "correct_choice_id": 58769,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14745,
    "choices": [
      {
        "id": 58941,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cross reactivity with exogenous antigen </span></span></span></p>"
      },
      {
        "id": 58942,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Innocent bystander effect </span></span></p>"
      },
      {
        "id": 58943,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to toxin secretion by streptococci </span></span></p>"
      },
      {
        "id": 58944,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Release of pyrogenic cytokines </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with signs and symptoms suggestive of acute rheumatic fever following a streptococcal pharyngitis. Which underlying mechanism is implicated in the pathogenesis of this condition?</span></span></span></p>",
    "unique_key": "Q8494686",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676687,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Cross reactivity with exogenous antigen </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cross-reactivity with exogenous antigen </strong>explains the mechanism whereby<strong> antibodies directed against the M proteins of streptococci</strong> cross-react with <strong>self-antigens </strong>in the<strong> heart and other tissues</strong>.</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acute rheumatic fever</strong> results from<strong> immune response </strong>to <strong>group A streptococci (Strep. pyogenes)</strong> which <strong>cross-reacts </strong>with <strong>host tissues. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>antibodie</strong>s directed against the<em> <strong>M proteins </strong>of streptococci</em> <strong>cross react</strong> with the<strong> self antigens in the heart</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In addition,<strong> CD4+ T cells specific </strong>for <strong>streptococcal peptides </strong>also react with <strong>self proteins </strong>in the <strong>heart </strong>and <em>produce <strong>macrophage activating cytokines</strong></em><strong>. </strong>So, the damage to the heart tissue is a combination of<strong> antibody and T-cell mediated reactions</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> innocent bystander effect </strong>is a mechanism where<strong> tissue damage </strong>occurs as a result of<strong> immune response against </strong>an <strong>infectious agent </strong>but is<strong> not the primary pathogenic </strong>mechanism in <strong>acute rheumatic fever.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While<strong> streptococci do secrete toxins</strong>, these are <strong>not </strong>the primary cause of the pathology seen in <strong>acute rheumatic fever,</strong> which is more related to the <strong>immune response</strong> than the direct effect of<strong> toxins.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pyrogenic cytokines</strong> contribute to the symptoms of <strong>inflammation and fever,</strong> but the release of such<strong> cytokines </strong>is <strong>not </strong>the initial trigger for the development of<strong> acute rheumatic fever.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acute rheumatic fever </strong>is an <strong>autoimmune condition </strong>triggered by the <strong>immune response to group A streptococcal infection</strong>, which <strong>cross-reacts with host tissue</strong>s leading to<strong> heart, joint, skin, and brain tissue damage. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 562)</span></span></em></strong></p>",
    "correct_choice_id": 58941,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14852,
    "choices": [
      {
        "id": 59368,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic bronchitis </span></span></span></p>"
      },
      {
        "id": 59369,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchial asthma </span></span></span></p>"
      },
      {
        "id": 59370,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchiectasis </span></span></p>"
      },
      {
        "id": 59371,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lobar pneumonia</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly male who had suffered Parkinson&#39;s disease for 15 years, developed fever, cough with yellow &quot;phlegm&quot; and breathlessness for 3 days. These symptoms were associated with a sharp, stabbing pain over her left lower chest that was worse when he took a deep breath. He was admitted to hospital with signs of septicaemia - high fever, increased heart rate (130/min) and decreased blood pressure (80/50). There was decreased air entry and a pleural rub over her left lower chest. She died on the same day. The presence of alveoli filled with exudates with the air being displaced converting the lung into a solid organ suggests which of the following diseases? </span></span></span></p>",
    "unique_key": "Q2240174",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676674,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Lobar pneumonia </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/29/picture1.jpg\" style=\"height:305px; width:1000px\" /></span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chronic bronchitis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic bronchitis is characterized by<strong> inflammation of the bronchi, </strong>leading to <strong>chronic cough and excessive mucus production</strong>. It does not typically result in the solidification of lung tissue.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Bronchial asthma:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asthma is characterized by <strong>reversible airway obstruction due to bronchospasm and inflammation</strong>. It does not cause the solidification of lung tissue seen in lobar pneumonia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Bronchiectasis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchiectasis involves the<strong> dilation and destruction of bronchi</strong>, leading to <strong>chronic cough and recurrent infections</strong>. While it can cause<strong> lung damage</strong>, it <strong>doesn&#39;t result </strong>in the same pattern of <strong>solidification </strong>as seen in lobar pneumonia</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of<strong> alveoli filled with exudates </strong>with the <strong>air being displaced </strong>converting the <strong>lung into a solid organ </strong>suggests <strong>lobar pneumonia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 708) </span></em></strong></span></span></p>",
    "correct_choice_id": 59371,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14841,
    "choices": [
      {
        "id": 59324,
        "text": "<p><span style=\"font-size:12pt;\">Cavitation</span></p>"
      },
      {
        "id": 59325,
        "text": "<p><span style=\"font-size:12.0pt;\">Caseation</span></p>"
      },
      {
        "id": 59326,
        "text": "<p><span style=\"font-size:12.0pt;\">Calcification</span></p>"
      },
      {
        "id": 59327,
        "text": "<p><span style=\"font-size:12pt;\">Langhans giant cell</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A medical resident is reviewing the pathology of tuberculosis (TB) with their attending. They are trying to differentiate the features of primary TB from secondary (reactivation) TB. Which of the following is least likely to be found in primary tuberculosis?</span></p>",
    "unique_key": "Q6121423",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676719,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Cavitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Cavitation:</strong> Cavitation is<strong> more </strong>characteristic of <strong>secondary TB</strong>, occurring when <strong>previously sensitized host defenses mobilize </strong>to contain a <strong>reactivated infection, </strong>resulting in <strong>caseous necrosis </strong>and <strong>cavity formation </strong>in the lungs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B: Caseation:</strong> Caseation, which is a<strong> form of necrosis </strong>associated with <strong>TB</strong>, can occur in <strong>both primary and secondary tuberculosis </strong>as part of the <strong>granuloma formation process</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C: Calcification:</strong> Calcification in <strong>primary TB </strong>is part of the <strong>Ghon complex</strong>, representing <strong>healing and containment of the infection</strong>, often seen in primary TB lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: Langhans giant cell:</strong> Langhans giant cells are a type of <strong>multinucleated giant cell </strong>seen in <strong>granulomas </strong>and can be found in both <strong>primary and secondary TB </strong>as part of the <strong>body's immune response to the infection</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Cavitation </strong>is<strong> more </strong>frequently associated with<strong> secondary tuberculosis, </strong>where a <strong>previously sensitized host's immune response </strong>leads to <strong>caseous necrosis and cavity formation</strong>. This feature is<strong> less </strong>commonly observed in <strong>primary tuberculosis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th/ </sup>375)</strong></i></span></p>",
    "correct_choice_id": 59324,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14754,
    "choices": [
      {
        "id": 58977,
        "text": "<p><span style=\"font-size:12pt;\">Mitral valve</span></p>"
      },
      {
        "id": 58978,
        "text": "<p><span style=\"font-size:12pt;\">Aortic valve</span></p>"
      },
      {
        "id": 58979,
        "text": "<p><span style=\"font-size:12pt;\">Pulmonary valve</span></p>"
      },
      {
        "id": 58980,
        "text": "<p><span style=\"font-size:12pt;\">Tricuspid valve</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In patients with a history of intravenous drug use, which heart valve is most commonly affected by infective endocarditis?</span></p>",
    "unique_key": "Q7388792",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676690,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Tricuspid valve</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> most common heart valve </strong>involved in <strong>intravenous (IV) drug </strong>users is the <strong>tricuspid valve. Intravenous drug </strong>use can introduce <strong>bacteria into the bloodstream</strong>, leading to<strong> infections </strong>on heart valves. The <strong>tricuspid valve </strong>is particularly <strong>susceptible </strong>due to the direct <strong>flow of blood </strong>from the<strong> venous system into the right atrium and then the right ventricle</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Intravenous drug </strong>use predisposes individuals to<strong> infective endocarditis </strong>predominantly involving the <strong>tricuspid valve </strong>due to the <strong>direct flow of potentially infected blood </strong>from<strong> venous circulation to the right side of the heart</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Common Sites of Involvement in IE:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_kke98Lh.png\" width=\"931\" height=\"202\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup> 563)</strong></span></p>",
    "correct_choice_id": 58980,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14842,
    "choices": [
      {
        "id": 59328,
        "text": "<p><span style=\"font-size:12pt;\">WBC\u2019s fill the alveoli</span></p>"
      },
      {
        "id": 59329,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">RBC\u2019s fill the alveoli</span></p>"
      },
      {
        "id": 59330,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Organisms fill the alveoli</span></p>"
      },
      {
        "id": 59331,
        "text": "<p><span style=\"font-size:12pt;\">Accumulation of fibrin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 45-year-old man presents to the emergency department with a three-day history of productive cough, fever, and pleuritic chest pain. Chest X-ray reveals lobar consolidation in the right lower lobe. On histopathological examination, the affected lung tissue shows grey hepatisation. Which of the following is a finding of this patient?</span></p>",
    "unique_key": "Q1128369",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676720,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Accumulation of fibrin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Accumulation of fibrin:</strong> During the <strong>grey hepatisation stage of pneumonia</strong>, there is a persistent <strong>fibrinopurulent </strong>exudate with the <strong>breakdown of red blood cell</strong>s, leading to a <strong>greyish appearance of lung tissue </strong>due to an ongoing <strong>inflammatory response.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: WBCs fill the alveoli:</strong> While <strong>white blood cells </strong>are present <strong>in the alveoli </strong>during<strong> pneumonia</strong>, the term <strong>\"grey hepatisation\" </strong>does not specifically refer to this feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B: RBCs fill the alveoli:</strong> Red blood cells contribute to the<strong> earlier stage </strong>known as <strong>red hepatisation, </strong>not the grey hepatisation stage of pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C: Organisms fill the alveoli:</strong> While<strong> infectious organisms </strong>cause the pneumonia, the term \"<strong>grey hepatisation</strong>\" refers to the stage characterized by the<strong> breakdown of red blood cells and inflammatory cells</strong>, rather than the<strong> presence of organisms.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Grey hepatisation </strong>in pneumonia is characterized by the<strong> accumulation of fibrin </strong>and <strong>breakdown of red blood cells</strong>, with a <strong>predominance of leukocytes</strong>, corresponding with a more <strong>advanced stage of lung tissue consolidation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stages of Lobar Pneumonia:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_P6CqTMP.png\" width=\"1390\" height=\"340\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 706)&nbsp;</strong></span></p>",
    "correct_choice_id": 59331,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14704,
    "choices": [
      {
        "id": 58777,
        "text": "<p><span style=\"font-size:16px;\">Granulomatosis with Polyangitis&nbsp;</span></p>"
      },
      {
        "id": 58778,
        "text": "<p><span style=\"font-size:16px;\">IgA Vasculitis&nbsp;</span></p>"
      },
      {
        "id": 58779,
        "text": "<p><span style=\"font-size:12pt;\">Microscopic polyangiitis</span></p>"
      },
      {
        "id": 58780,
        "text": "<p><span style=\"font-size:16px;\">Eosinophilic Granulomatosis with Polyangiitis&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">ANCA is seen in all except:</span></p>",
    "unique_key": "Q3883589",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676716,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. B) IgA Vasculitis&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B:&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>IgA Vasculitis </strong>is <strong>not typically </strong>associated with<strong> ANCA</strong>. It is an<strong> immune-mediated vasculitis </strong>that primarily affects <strong>small vessels </strong>and is often characterized by <strong>palpable purpura, abdominal pain, joint pain, and kidney involvement</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Antineutrophil Cytoplasmic Antibodies (ANCA) </strong>are <strong>autoantibodies </strong>that target components of <strong>neutrophils' cytoplasmic granules. ANCA-associated vasculitides (AAV) </strong>are a group of<strong> autoimmune diseases </strong>characterized by inflammation of <strong>small blood vessels</strong>. Among the options provided:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Granulomatosis with Polyangiitis (GPA): </strong>Granulomatosis with Polyangiitis is associated with PR 3ANCA (directed against proteinase 3),&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Microscopic polyangiitis: </strong>Microscopic polyangiitis is associated with MPO ANCA, directed against myeloperoxidase (MPO).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D.</strong> <strong>Eosinophilic Granulomatosis with Polyangiitis (EGPA):&nbsp;</strong> Eosinophilic Granulomatosis with Polyangiitis is associated with MPO ANCA directed against myeloperoxidase (MPO).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Antineutrophil cytoplasmic antibodies (ANCA) are not seen with IgA Vasculitis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 512)</strong></span></p>",
    "correct_choice_id": 58778,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14849,
    "choices": [
      {
        "id": 59356,
        "text": "<p><span style=\"font-size:12.0pt;\">Apex</span></p>"
      },
      {
        "id": 59357,
        "text": "<p><span style=\"font-size:12pt;\">Near bronchus</span></p>"
      },
      {
        "id": 59358,
        "text": "<p><span style=\"font-size:12.0pt;\">Subpleurally</span></p>"
      },
      {
        "id": 59359,
        "text": "<p><span style=\"font-size:12.0pt;\">Base</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 45-year-old patient, previously treated for pulmonary tuberculosis, presents with cough, hemoptysis, and weight loss. He has been diagnosed with reactivation of tuberculosis. This lesion is most likely to be located near:</span></p>",
    "unique_key": "Q7283795",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676672,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Apex</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><i><strong>&nbsp;</strong></i><strong>Reactivated tuberculosis </strong>(TB) typically occurs in areas of the lung where the<strong> oxygen tension is higher</strong>. Let's analyze each option:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Apex:</strong> This is a <strong>common site </strong>for <strong>reactivated TB</strong>. The apex of the lung has a relatively <strong>higher oxygen perfusion ratio</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong> <strong>Near bronchus:</strong> <strong>TB </strong>can occur <strong>near bronchi, </strong>but reactivation often happens in areas with <strong>higher oxygen tension.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Subpleurally: TB can </strong>occur <strong>subpleurally, </strong>but reactivation is more common in areas with higher oxygen tension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong> <strong>Base:</strong> The base of the<strong> lung has lower oxygen perfusion ratio</strong>, making it<strong> less favorable </strong>for <strong>reactivated TB.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Reactivated tuberculosis </strong>(TB) typically occurs in<strong> apex of lung.</strong></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><i><strong>(Ref: Robbins 10th 370)&nbsp;</strong></i></span></p>",
    "correct_choice_id": 59356,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14788,
    "choices": [
      {
        "id": 59113,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Juvenile polyp</span></p>"
      },
      {
        "id": 59114,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Adenomatous polyp</span></p>"
      },
      {
        "id": 59115,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Tubulovillous polyp</span></p>"
      },
      {
        "id": 59116,
        "text": "<p><span style=\"font-size:12pt;\">Peutz Jegher polyp</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 17-year-old presented with intussusception and was found to be having a polyp. A biopsy is taken and is shown alongside. What is the likely diagnosis in this individual?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/08/picture1.jpg\" alt=\"\" width=\"300\" height=\"288\"></span></p>",
    "unique_key": "Q1627453",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676703,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Peutz Jegher polyp</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">The<strong> Peutz-Jegher polyp </strong>is part of an <strong>autosomal dominant syndrome </strong>characterized by <strong>hamartomatous polyps </strong>throughout the <strong>gastrointestinal tract</strong>. The biopsy showing an <strong>arborizing pattern aligns </strong>with the diagnosis of<strong> Peutz-Jeghers syndrome, </strong>fitting with the patient's clinical presentation</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>Juvenile polyps</strong> <strong>do not </strong>typically cause <strong>intussusception in older children or teenagers </strong>and are not characterized by an arborizing architecture on histology.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Adenomatous polyps</strong> are <strong>neoplastic </strong>and could be associated with <strong>intussusception; </strong>however, they <strong>do not show </strong>the <strong>arborizing histological pattern </strong>seen in the provided biopsy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Tubulovillous adenomas</strong> are <strong>not typically associated with the genetic syndrome </strong>in question and <strong>do not </strong>have the <strong>arborizing architecture </strong>shown in the biopsy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>histological pattern of the polyp </strong>and the clinical presentation of<strong> intussusception at a young age </strong>suggest a diagnosis of<strong> Peutz-Jeghers syndrome. </strong>This condition is associated with <strong>hamartomatous polyps </strong>that have a <strong>tree-like architectural pattern </strong>and <strong>increased cancer risk.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 809-810</strong></span></p>",
    "correct_choice_id": 59116,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14774,
    "choices": [
      {
        "id": 59057,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Rectum</span></p>"
      },
      {
        "id": 59058,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Colon</span></p>"
      },
      {
        "id": 59059,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Esophagus</span></p>"
      },
      {
        "id": 59060,
        "text": "<p><span style=\"font-size:12pt;\">Jejunum</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In Peutz-Jeghers syndrome, polyps are mainly seen in:</span></p>",
    "unique_key": "Q8662399",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676699,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Jejunum</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>polyps of Peutz-Jeghers syndrome (PJS) </strong>are <strong>most com\u00admon in the small intestine especially jejunum</strong>, although they may occur in the stomach and colon, and, with much lower frequency, in the bladder and lungs.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The<strong> jejunum is the most frequently </strong>affected site, and patients with <strong>Peutz-Jeghers syndrome </strong>often develop polyps here that can cause complications like <strong>intussusception.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;Rectal involvement </strong>is possible in<strong> Peutz-Jeghers syndrome</strong>, but it is <strong>not the primary site of polyp </strong>development.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.&nbsp;</strong>The <strong>colon can be involved</strong>, but the <strong>small intestine</strong>, particularly the <strong>jejunum, is the most common site for polyps </strong>in this syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;Esophageal polyps are quite<strong> uncommon in Peutz-Jeghers syndrome</strong>, with the condition typically affecting the small intestine.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Jejunum </strong>is the<strong> most common site </strong>for the characteristic<strong> hamartomatous polyps of Peutz-Jeghers syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Location of Polyps in PJS:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_x5vzrZQ.png\" width=\"1033\" height=\"293\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref:</u> Robbins 10<sup>th</sup>/ 809</strong></span></p>",
    "correct_choice_id": 59060,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14773,
    "choices": [
      {
        "id": 59053,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Remnant of proximal part of vitellointestinal duct</span></p>"
      },
      {
        "id": 59054,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Presents with periumbilical pain</span></p>"
      },
      {
        "id": 59055,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Present in 3% of the population</span></p>"
      },
      {
        "id": 59056,
        "text": "<p><span style=\"font-size:12pt;\">Lies on the anti-mesenteric border</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is false about Meckel\u2019s diverticulitis?</span></p>",
    "unique_key": "Q9101451",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676698,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Present in 3% of the population</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Meckel diverticulum </strong>occurs as a result of <strong>failed involu\u00adtion of the vitelline duct, </strong>which connects the<strong> lumen of the developing gut to the yolk sac</strong>. This<strong> solitary divertic\u00adulum extends from the antimesenteric side of the bowel.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>\u201crule of 2s\u201d</strong> is often used to help remember charac\u00adteristics of Meckel diverticula, which:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">The <strong>prevalence of Meckel's diverticulum </strong>in the <strong>general population is 2%, </strong>not 3%, making this statement false.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">Affects<strong> 2% of the population</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">Are generally present <strong>within 2 feet </strong>(60 cm) of the ileocecal valve</span></p></li><li><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">Are approximately <strong>2 inches</strong> (5 cm) long</span></p></li><li><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">Are <strong>twice as common in males</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">Are <strong>most often symptomatic by age 2</strong> (<i><strong>only approximately 4%</strong></i> are ever symptomatic).</span></p></li><li><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">Has <strong>2 types</strong> of mucosa: <strong>gastric and pancreatic mucosa</strong>.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>The proximal part of the vitellointestinal duct</strong> is the correct embryological origin of Meckel's diverticulum.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Symptoms of Meckel's diverticulitis</strong> may include <strong>periumbilical pain</strong>, which sometimes leads to a clinical picture resembling that of acute appendicitis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option D.&nbsp;Meckel's&nbsp;</strong>diverticulum is indeed located on the<strong> anti-mesenteric border of the ileum</strong>, which is the<strong> edge of the intestine </strong>that is <strong>not attached to the mesentery</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Meckel's diverticulum </strong>is present in<strong> 2% of the population</strong>, not 3%.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 755</strong></span></p>",
    "correct_choice_id": 59055,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14699,
    "choices": [
      {
        "id": 58757,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cell arteritis </span></span></span></p>"
      },
      {
        "id": 58758,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takayasu arteritis </span></span></span></p>"
      },
      {
        "id": 58759,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAN </span></span></p>"
      },
      {
        "id": 58760,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microscopic polyangiitis </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old man presents with a month-long history of malaise, weight loss, and renal impairment. His urinalysis shows microscopic hematuria and proteinuria. A chest X-ray reveals bilateral nodular infiltrates. Serology tests are positive for p-ANCA. Small vessels vasculitis is seen in </span></span></span></p>",
    "unique_key": "Q1047408",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676713,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Microscopic polyangiitis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Microscopic polyangiitis </strong>(MPA) is a type of <strong>small-vessel vasculitis</strong>. It is characterized by <strong>inflammation of small blood vessels</strong>, including <strong>capillaries</strong>, <strong>venules</strong>, and <strong>arterioles</strong>. <strong>MPA </strong>is often associated with the <strong>presence of antineutrophil cytoplasmic antibodies </strong>(ANCA) and primarily <strong>affects the kidneys and lungs</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Giant Cell Arteritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cell arteritis is primarily a <strong>large- and medium-sized vessel vasculitis</strong>. It typically involves large arteries such as the temporal arteries.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Takayasu Arteritis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takayasu arteritis is a <strong>large-vessel vasculitis </strong>that <strong>affects the aorta </strong>and its <strong>major branches</strong>. It usually involves the large vessels rather than the small vessels.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Polyarteritis Nodosa (PAN):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyarteritis nodosa is a <strong>medium-sized vessel vasculitis </strong>that <strong>affects multiple organs</strong>. It is not typically considered a small-vessel vasculitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is a <strong>small-vessel vasculitis </strong>commonly <strong>associated with p-ANCA</strong>, involving the <strong>kidneys and lungs</strong>, which aligns with the patient&#39;s presentation of <strong>renal impairment</strong>, <strong>pulmonary nodules</strong>, and <strong>positive serology</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 513) </span></span></em></strong></p>",
    "correct_choice_id": 58760,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14743,
    "choices": [
      {
        "id": 58933,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibroblasts and collagen</span></p>"
      },
      {
        "id": 58934,
        "text": "<p><span style=\"font-size:12.0pt;\">Granulation tissue</span></p>"
      },
      {
        "id": 58935,
        "text": "<p><span style=\"font-size:12.0pt;\">Neutrophilic infiltration surrounding coagulative necrosis</span></p>"
      },
      {
        "id": 58936,
        "text": "<p><span style=\"font-size:12.0pt;\">Granulomatous inflammation</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 45-year-old male with acute myocardial infarction passed away two days post-admission. Autopsy revealed transmural coagulative necrosis in the myocardium. Which microscopic feature would most likely be present at this stage of myocardial infarction?</span></p>",
    "unique_key": "Q4759153",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676685,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Neutrophilic infiltration surrounding coagula\u00adtive necrosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In the<strong> early stages of myocardial infarction</strong>, <strong>coagulative necrosis</strong> is typically accompanied by <strong>neutrophilic infiltration</strong>, indicating the <strong>acute inflammatory response</strong> to <strong>tissue injury. </strong>This response occurs before the <strong>later stages of healing</strong> with features like <strong>fibroblasts</strong> and <strong>collagen deposition.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Neutrophilic infiltration </strong>surrounding <strong>coagulative necrosis </strong>is characteristic of the<strong> acute inflammatory response </strong>seen in the <strong>initial </strong>phase of <strong>myocardial infarction</strong>, which would correspond to the timeline given in the scenario.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong>&nbsp;<strong>Fibroblasts and collagen </strong>are typically present during the <strong>healing and scar formation</strong> phase of <strong>myocardial infarction</strong>, which generally occurs <strong>several days to weeks </strong>after the initial event.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Granulation tissue </strong>is part of the <strong>proliferative phase of healing</strong>, usually seen about a<strong> week after an MI</strong>, not within the first few days.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Granulomatous inflammation </strong>is <strong>not </strong>a feature of<strong> myocardial infarction</strong>; it is associated with <strong>chronic inflammation </strong>due to specific diseases such as <strong>tuberculosis or sarcoidosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>In the early stages </strong>of <strong>myocardial infarction</strong>, typically <strong>within the first 3 days</strong>, <strong>neutrophils </strong>are the first<strong> inflammatory cells </strong>to respond to the<strong> necrotic tissue</strong>, reflecting an <strong>acute inflammatory response.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Timeline of histological changes after myocardial infarction:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_V4Zj3E4.png\" width=\"1140\" height=\"554\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 547)</strong></span></p>",
    "correct_choice_id": 58935,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14765,
    "choices": [
      {
        "id": 59021,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Commonest site is ascending colon and cecum</span></p>"
      },
      {
        "id": 59022,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Flask shaped ulcer</span></p>"
      },
      {
        "id": 59023,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Perforation is common</span></p>"
      },
      {
        "id": 59024,
        "text": "<p><span style=\"font-size:12pt;\">Paucity of inflammatory cells</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">A 34-year-old male presents with a two-week history of bloody diarrhea and abdominal pain. Colonoscopy reveals several ulcers in the cecum and ascending colon.&nbsp; The patient has a travel history to an area with poor sanitation. </span><span style=\"font-size:12.0pt;\">All are true about amoebic ulcer except:</span></p>",
    "unique_key": "Q6152872",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676695,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Perforation is common</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">Contrary to this statement,<strong> perforation is not a common complication of amoebic ulcers</strong>; it is relatively rare and suggests other underlying or superimposed pathologies if present.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>The cecum and ascending colon</strong> are indeed the <strong>most common sites for amoebic ulcers</strong>, matching the patient's colonoscopic findings.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Flask-shaped ulcers are indicative of amoebic colitis</strong>, where the invading <strong>Entamoeba histolytica </strong>causes <strong>deep ulcers with undermined edges</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>The histology of amoebic colitis</strong> typically shows <strong>minimal inflammation</strong>, as the <strong>trophozoites </strong>of Entamoeba histolytica cause <strong>cell lysis and necrosis </strong>without inducing a significant<strong> inflammatory response.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Amoebic ulcers</strong> are typically seen in the<strong> colon, p</strong>articularly in the <strong>cecum and ascending colon</strong>. They are associated with <strong>amoebic colitis </strong>caused by the <strong>protozoan parasite Entamoeba histolytica</strong>. These ulcers are usually <strong>deep with undermined edges</strong>, giving them the<strong> flask-shaped appearance</strong>. <strong>Perforation </strong>is <strong>not </strong>a common feature of <strong>amoebic ulcers</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/17/screenshot-2024-04-17-180342.png\" alt=\"\" width=\"500\" height=\"313\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 796</strong></span></p>",
    "correct_choice_id": 59023,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14867,
    "choices": [
      {
        "id": 59428,
        "text": "<p><span style=\"font-size:12.0pt;\">Silicosis</span></p>"
      },
      {
        "id": 59429,
        "text": "<p><span style=\"font-size:12.0pt;\">Byssinosis</span></p>"
      },
      {
        "id": 59430,
        "text": "<p><span style=\"font-size:12.0pt;\">Asbestosis</span></p>"
      },
      {
        "id": 59431,
        "text": "<p><span style=\"font-size:12.0pt;\">Bagassosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Ferruginous bodies are seen in:</span></p>",
    "unique_key": "Q4465712",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676682,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Asbestosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/29/picture2.jpg\" alt=\"\" width=\"1000\" height=\"449\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Asbestosis:</strong> Asbestosis is a<strong> lung disease </strong>caused by <strong>the inhalation of asbestos fibers</strong>.<strong> Ferruginous bodies </strong>are specifically associated with <strong>asbestos exposure</strong>. These bodies are formed when <strong>iron-containing proteins coat asbestos fibers </strong>in the lungs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Silicosis:</strong> Silicosis is a<strong> lung disease </strong>caused by the<strong> inhalation of crystalline silica dust.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Byssinosis:</strong> Byssinosis, also known as <strong>\"brown lung disease\" or \"Monday fever</strong>,\" is an occupational lung disease caused by the inhalation of<strong> cotton, flax, or hemp dust.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Bagassosis:&nbsp;</strong>Bagassosis is a type of<strong> pneumoconiosis </strong>caused by the inhalation of dust from<strong> moldy sugarcane.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ferruginous bodies </strong>are <strong>not typically </strong>associated with<strong> silicosis, byssinosis and bagassosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 701)</strong></i></span></p>",
    "correct_choice_id": 59430,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14770,
    "choices": [
      {
        "id": 59041,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Sigmoid colon</span></p>"
      },
      {
        "id": 59042,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Transverse colon</span></p>"
      },
      {
        "id": 59043,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cecum</span></p>"
      },
      {
        "id": 59044,
        "text": "<p><span style=\"font-size:12pt;\">Liver</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">A 40-year-old male presents with a history of bloody diarrhea and abdominal pain. A colonoscopy reveals ulcerations. Biopsies are taken, and the patient is diagnosed with amoebic colitis caused by Entamoeba histolytica. </span><span style=\"font-size:12.0pt;\">The most common site for amoebiasis:</span></p>",
    "unique_key": "Q6294539",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676697,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Cecum</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Amoebic ulcers </strong>are typically seen in the<strong> colon</strong>, particularly in the <strong>cecum and ascending colon</strong>. They are associated with<strong> amoebic colitis </strong>caused by the protozoan parasite<strong> Entamoeba histolytica. </strong>These ulcers are usually deep with <strong>undermined edges, </strong>giving them the<strong> flask-shaped appearance.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">The <strong>cecum, followed by the ascending colon</strong>, is the most frequent location for<strong> amoebic ulcers </strong>within the colon due to factors such as<strong> stasis and bacterial content</strong>, providing a <strong>conducive environment for Entamoeba histolytica.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>The sigmoid colon</strong> can be affected by amoebic colitis, but it is <strong>not the most common site </strong>of amoebic involvement in the colon.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B.&nbsp;Amoebiasis </strong>may involve the <strong>transverse colon</strong>, but such involvement is<strong> less common </strong>than in <strong>the cecum and ascending colon</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.&nbsp;The liver </strong>is indeed the most common <strong>extraintestinal site </strong>affected by <strong>amoebiasis, </strong>often resulting from <strong>hematogenous spread from the intestinal lesion</strong>, but within the intestine itself, the <strong>cecum is the most commonly affected site</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">The <strong>cecum </strong>is the <strong>most common site </strong>for <strong>amoebiasis </strong>within the <strong>intestine</strong>, presenting typically with<strong> deep ulcers </strong>that have <strong>undermined edges</strong>, often giving a<strong> flask-shaped appearance.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10th /795</strong></span></p>",
    "correct_choice_id": 59043,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14684,
    "choices": [
      {
        "id": 58697,
        "text": "<p><span style=\"font-size:12pt;\">Henoch-Schonlein Purpura</span></p>"
      },
      {
        "id": 58698,
        "text": "<p><span style=\"font-size:12pt;\">Wegner\u2019s granulomatosis</span></p>"
      },
      {
        "id": 58699,
        "text": "<p><span style=\"font-size:12pt;\">Giant cell Vasculitis</span></p>"
      },
      {
        "id": 58700,
        "text": "<p><span style=\"font-size:12pt;\">Kawasaki\u2019s disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 5\u2011year\u2011old child presents with perivascular IgA deposition and neutrophilic collection. There is erythematous rash on the lower limbs and non-blanching purpura. The likely diagnosis in the child is:</span></p>",
    "unique_key": "Q4817766",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676710,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Henoch-Schonlein Purpura</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>HSP </strong>is a <strong>small-vessel vasculitis </strong>that commonly occurs in <strong>children</strong>. It is characterized by <strong>perivascular IgA deposition</strong>,<strong> neutrophilic infiltration, </strong>and involvement of<strong> small blood vessels</strong>. Skin manifestations often include a<strong> rash on the lower limbs</strong>, which may be <strong>erythematous and have non-blanching purpura.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B: Wegener's Granulomatosis: </strong>Wegener's granulomatosis is a form of <strong>granulomatosis with polyangiitis (GPA</strong>), which primarily affects the<strong> upper and lower respiratory tracts and kidneys</strong>. It is not typically associated with IgA deposition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: Giant Cell Vasculitis: </strong>Giant cell vasculitis, such as <strong>giant cell arteritis</strong>, usually occurs in <strong>older </strong>individuals and involves<strong> large and medium-sized arteries</strong>. It is<strong> not </strong>commonly seen in <strong>children </strong>and does not present with the characteristic skin findings described.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: Kawasaki's Disease: </strong>Kawasaki's disease is a<strong> vasculitis </strong>that affects <strong>medium-sized vessels</strong>, particularly the <strong>coronary arteries. </strong>While it can present with a<strong> rash</strong>, it is <strong>not </strong>associated with <strong>perivascular IgA deposition</strong>, which is a characteristic feature of <strong>HSP.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Henoch-Sch\u00f6nlein purpura (HSP) </strong>is a<strong> small-vessel vasculitis </strong>that most commonly occurs in<strong> children </strong>and is characterized by a<strong> tetrad of palpable purpura, abdominal pain, arthralgia, and renal involvement. </strong>It is often preceded by an <strong>upper respiratory tract infection </strong>and is associated with<strong> IgA immune complex deposition in the affected vessels.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 561)</strong></i></span></p>",
    "correct_choice_id": 58697,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14869,
    "choices": [
      {
        "id": 59436,
        "text": "<p><span style=\"font-size:12pt;\">Diffuse alveolar damage</span></p>"
      },
      {
        "id": 59437,
        "text": "<p><span style=\"font-size:12pt;\">Calcify pleural plaques</span></p>"
      },
      {
        "id": 59438,
        "text": "<p><span style=\"font-size:12pt;\">Diffuse pulmonary interstitial fibrosis</span></p>"
      },
      {
        "id": 59439,
        "text": "<p><span style=\"font-size:12.0pt;\">Mesothelioma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">All of the following are seen in asbestosis except:</span></p>",
    "unique_key": "Q8082997",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676683,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Diffuse alveolar damage</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Diffuse alveolar damage:&nbsp;</strong>is <strong>not </strong>a typical finding in<strong> asbestosis</strong>. Asbestosis is characterized by <strong>diffuse pulmonary interstitial fibrosis </strong>rather than <strong>diffuse alveolar damage.</strong> Diffuse alveolar damage is more commonly associated with conditions such as<strong> acute respiratory distress syndrome (ARDS).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Calcified pleural plaques:&nbsp;</strong>This is a characteristic feature of<strong> asbestosis</strong>. Asbestos exposure can lead to the <strong>formation of pleural plaques</strong>, which are <strong>areas of fibrous thickening and calcification on the pleura</strong>. These <strong>plaques </strong>are a <strong>hallmark of asbestos-related lung disease.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Diffuse pulmonary interstitial fibrosis:&nbsp;</strong>This is a<strong> correct</strong> option. <strong>Asbestosis </strong>is primarily characterized by the<strong> deposition of asbestos fibers in the lungs</strong>, leading to <strong>pulmonary fibrosis</strong>. It involves the <strong>interstitium of the lungs</strong>, causing <strong>scarring and impairment of lung function.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Mesothelioma:&nbsp;</strong>This is a <strong>correct</strong> option. <strong>Asbestos exposure </strong>is a well-established risk factor for the development of <strong>mesothelioma, a malignant tumor of the mesothelial cells </strong>lining the<strong> pleura, peritoneum, and other serosal surfaces</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Diffuse alveolar damage </strong>is <strong>not </strong>typically associated with <strong>asbestosis </strong>but is <strong>more </strong>indicative of acute conditions such as <strong>acute respiratory distress syndrome (ARDS), </strong>distinguishing it from the <strong>chronic fibrotic changes </strong>seen in <strong>asbestosis</strong>.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 672)</strong></i></span></p>",
    "correct_choice_id": 59436,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14766,
    "choices": [
      {
        "id": 59025,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Perforation</span></p>"
      },
      {
        "id": 59026,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Stricture formation</span></p>"
      },
      {
        "id": 59027,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hemorrhage</span></p>"
      },
      {
        "id": 59028,
        "text": "<p><span style=\"font-size:12pt;\">Sepsis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All are complication of typhoid ulcers except:</span></p>",
    "unique_key": "Q5848641",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676696,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Stricture formation</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Stricture formation is<strong> not usually seen with enteric fever</strong>. It is a <strong>feature with intestinal tuberculosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Perforation:</strong> Perforation is a well-known<strong> complication of typhoid ulcers</strong>. The ulcers can <strong>penetrate </strong>through the <strong>intestinal wall, leading to perforation </strong>and potentially causing<strong> peritonitis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Hemorrhage: Typhoid ulcers </strong>can cause<strong> bleeding, and hemorrhage </strong>is a recognized complication.<strong> Ulceration and erosion of blood vessels </strong>within the<strong> intestinal wall </strong>can result in <strong>gastrointestinal bleeding.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Sepsis:</strong> <strong>Perforation of typhoid ulcers </strong>can allow the <strong>entry of bacteria </strong>into the <strong>abdominal cavity, leading to sepsis</strong>. Sepsis is a <strong>severe, life-threatening complication </strong>that can result from the <strong>spread of bacteria and their toxins</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 791</strong></span></p>",
    "correct_choice_id": 59026,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14676,
    "choices": [
      {
        "id": 58665,
        "text": "<p><span style=\"font-size:12pt;\">Proliferative endarteritits</span></p>"
      },
      {
        "id": 58666,
        "text": "<p><span style=\"font-size:12pt;\">Necrotizing arteriolitis</span></p>"
      },
      {
        "id": 58667,
        "text": "<p><span style=\"font-size:12pt;\">Hyaline arteriolosclerosis</span></p>"
      },
      {
        "id": 58668,
        "text": "<p><span style=\"font-size:12pt;\">Cystic medial necrosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which of the following is the commonest histological finding in benign hypertension?&nbsp;<i>&nbsp;</i></span></p>",
    "unique_key": "Q6899283",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676707,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Hyaline arteriolosclerosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture20.jpg\" alt=\"\" width=\"1000\" height=\"272\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;Proliferative endarteritis</strong> is <strong>not </strong>the most common finding in <strong>benign hypertension. </strong>It involves <strong>inflammation and hyperplasia of the intima (inner layer) of arteries</strong>, often seen in conditions like vasculitis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Necrotizing arteriolitis </strong>involves <strong>necrosis of the arterioles,</strong> and while it can occur in severe forms of <strong>hypertension,</strong> it is <strong>not </strong>the most common histological finding in<strong> benign hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.&nbsp;Cystic medial necrosis </strong>is associated with conditions like <strong>Marfan syndrome </strong>and is characterized by <strong>degeneration and cystic</strong> changes in the<strong> arterial media</strong>. It is<strong> not </strong>a common finding in<strong> benign hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>commonest histological </strong>finding in <strong>benign hypertension </strong>is <strong>Hyaline arteriolosclerosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ p492)</strong></i></span></p>",
    "correct_choice_id": 58667,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14758,
    "choices": [
      {
        "id": 58993,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Less than 1 hour </span></span></span></p>"
      },
      {
        "id": 58994,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Within 24 hours </span></span></span></p>"
      },
      {
        "id": 58995,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Within 1 week </span></span></span></p>"
      },
      {
        "id": 58996,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Within 1 month</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A myocardial infarct showing early granulation tissue has most likely occurred: </span></span></span></p>",
    "unique_key": "Q2883055",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676691,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Within 1 week </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Granulation tissue </strong>is a part of the healing process after a <strong>myocardial infarction (heart attack). </strong>It is typically seen within the <strong>first week </strong>following the infarct. During this phase of<strong> healing, inflammatory cells </strong>are replaced by<strong> granulation tissue</strong>, which consists of <strong>new blood vessels, fibroblasts, and other connective tissue elements.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Early granulation tissue</strong>, which consists of<strong> proliferating fibroblasts</strong>, <strong>new blood vessels (angiogenesis), </strong>and the resolution of the <strong>acute inflammatory infiltrate</strong>, typically appears between<strong> 4 and 7 days </strong>after an <strong>MI </strong>as part of the<strong> healing process.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Early granulation tissue </strong>does not develop<strong> less than 1 hour after an MI</strong>. The initial response is one of acute inflammation predominantly involving neutrophils.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Within 24 hours </strong>after an<strong> MI, coagulative necrosis </strong>begins to occur along with an <strong>acute inflammatory response</strong>, but granulation tissue is not yet present.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Within 1 month after an MI</strong>, the <strong>granulation tissue </strong>has usually matured into <strong>scar tissue</strong>, with<strong> dense collagen deposition, </strong>rather than early granulation tissue.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Early granulation tissue </strong>in the context of <strong>myocardial infarction </strong>typically occurs <strong>within 1 week </strong>after the event and signifies the replacement of <strong>inflammatory cells </strong>with <strong>new connective tissue elements and blood vessels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 548)</span></span></em></strong></p>",
    "correct_choice_id": 58995,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14667,
    "choices": [
      {
        "id": 58629,
        "text": "<p><span style=\"font-size:12pt;\">Polyarteritis nodosa</span></p>"
      },
      {
        "id": 58630,
        "text": "<p><span style=\"font-size:12pt;\">Systemic hypertension</span></p>"
      },
      {
        "id": 58631,
        "text": "<p><span style=\"font-size:12pt;\">Malignant hypertension</span></p>"
      },
      {
        "id": 58632,
        "text": "<p><span style=\"font-size:12pt;\">Wegeners disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 65-year-old woman complains of increased fatigue since last 2 years. Her serum creatinine and blood urea nitrogen are raised. USG shows both kidneys symmetrically reduced in size. Kidney biopsy done shows the following finding. What is the likely diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3qbCYsK.png\" width=\"557\" height=\"372\"></p>",
    "unique_key": "Q8190525",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676705,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Systemic hypertension</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This is <strong>hyaline arteriosclerosis</strong> of vessel wall seen in <strong>benign hypertension</strong> wherein the <strong>kidneys are symmetrically contracted</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Similar changes can also be seen in <strong>diabetes mellitus.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In <strong>systemic hypertension, </strong>especially <strong>long-standing and poorly controlled cases</strong>, <strong>hyaline arteriosclerosis of the vessel wall </strong>can occur, leading to symmetrically<strong> reduced kidney size</strong>. This finding is consistent with the<strong> patient\u2019s presentation and biopsy </strong>results.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:&nbsp;Polyarteritis nodosa </strong>typically presents with <strong>vasculitis and fibrinoid necrosis </strong>on kidney biopsy. It is characterized by <strong>segmental necrotizing inflammation of medium-sized arteries, </strong>which would be evident on histological examination.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Malignant hypertension </strong>typically presents with <strong>\"flea-bitten\" kidneys </strong>on imaging and demonstrates<strong> fibrinoid necrosis </strong>on kidney biopsy. This <strong>patient's presentation, including symmetrically reduced kidney size and the absence of fibrinoid necrosis</strong>, is not consistent with malignant hypertension.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Wegener's granulomatosis </strong>is characterized by<strong> granulomatous </strong>inflammation of the vessel wall. However, the histological findings described in the<strong> patient's kidney biopsy do not align with this diagnosis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Symmetrically reduced kidney size </strong>with<strong> hyaline arteriosclerosis </strong>of the vessel wall is indicative of <strong>systemic hypertension.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Onion-skinning of blood vessels in kidney is seen in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Malignant hypertension</span></li><li><span style=\"font-size:16px;\">Chronic transplant rejection</span></li><li><span style=\"font-size:16px;\">Thrombotic microangiopathies (e.g., HUS, TTP)</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ p492)</strong></span></p>",
    "correct_choice_id": 58630,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14738,
    "choices": [
      {
        "id": 58913,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lipoprotein</span></span></span></p>"
      },
      {
        "id": 58914,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
      },
      {
        "id": 58915,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxidised LDL</span></span></span></p>"
      },
      {
        "id": 58916,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homocysteine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A middle-aged male patient presents with angina on exertion. His cardiovascular risk profile includes hypercholesterolemia and smoking. On histological examination of an arterial biopsy from an atherosclerotic plaque, numerous foam cells are identified. Which of the following components in the patient&#39;s blood most likely contributed to the formation of these foam cells?</span></span></span></p>",
    "unique_key": "Q3023497",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676680,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Oxidised LDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The process described involves the<strong> formation of foam cells in atherosclerotic plaque</strong>. <strong>Foam cells</strong> are derived from <strong>macrophages </strong>that have<strong> engulfed modified low-density lipoproteins (LDL).</strong> In the pathogenesis of<strong> atherosclerosis, LDL cholesterol </strong>undergoes <strong>oxidative</strong> modifications, turning it into <strong>oxidized LDL</strong>. Oxidized LDL is more likely to be <strong>taken up by macrophages, </strong>leading to the <strong>formation of foam cells within the atherosclerotic plaque</strong>. The <strong>accumulation of foam cells </strong>contributes to the <strong>development and progression of atherosclerosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>oxidized LDL </strong>is readily taken up by <strong>macrophages through scavenger receptors</strong>, leading to<strong> foam cell formation</strong>, which is a<strong> hallmark of atherosclerotic plaque development.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipoproteins </strong>are the major carriers of<strong> cholesterol in the blood</strong>, but <strong>not all lipoproteins </strong>directly contribute to <strong>foam cell formation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>VLDL is a lipoprotein </strong>that primarily carries <strong>triglycerides; </strong>while it can contribute to <strong>plaque formation</strong>, it is not the most direct cause of foam cell formation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Homocysteine </strong>is <strong>an amino acid </strong>that has been linked to an<strong> increased risk of cardiovascular disease, </strong>but it does not directly lead to foam cell formation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxidized LDL </strong>is crucial in the <strong>pathogenesis of atherosclerosis </strong>as it is readily<strong> engulfed by macrophages </strong>to become <strong>foam cells</strong>, which are a defining feature of<strong> atherosclerotic plaques</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Robbins 10<sup>th</sup> 493-5</span></span></strong></p>",
    "correct_choice_id": 58915,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14686,
    "choices": [
      {
        "id": 58705,
        "text": "<p><span style=\"font-size:12pt;\">Wegener\u2019s granulomatosis</span></p>"
      },
      {
        "id": 58706,
        "text": "<p><span style=\"font-size:12pt;\">Buerger\u2019s disease</span></p>"
      },
      {
        "id": 58707,
        "text": "<p><span style=\"font-size:12pt;\">Takayasu\u2019s arteritis</span></p>"
      },
      {
        "id": 58708,
        "text": "<p><span style=\"font-size:12pt;\">Microscopic polyangiitis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In the evaluation of a patient with systemic vasculitis, which of the following conditions is least likely to show granulomatous inflammation on biopsy?</span></p>",
    "unique_key": "Q4405981",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676711,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. D) Microscopic polyangiitis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D:&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Microscopic polyangiitis </strong>does <strong>not </strong>involve <strong>granulomatous inflammation</strong>; rather, it is <strong>associated with necrotizing inflammation </strong>that <strong>affects small vessels</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">It is MPO-ANCA positive vasculitis disorder, characterized by pauci-immune glomerulonephritis and pulmonary capillaritis.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong> <strong>Wegener's granulomatosis</strong>, now referred to as Granulomatosis with polyangiitis is known for <strong>necrotizing granulomatous inflammation</strong>, particularly affecting the respiratory tract and the kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">c-ANCA positive (PR3-ANCA)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B:&nbsp;Buerger\u2019s disease </strong>is characterized by <strong>granulomatous inflammation </strong>of <strong>small- and medium-sized arteries </strong>and <strong>veins </strong>in the extremities, especially in smokers</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Associated with segmental thrombosing vasculitis with microabscesses and granulomatous inflammation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:&nbsp;Takayasu\u2019s arteritis </strong>exhibits <strong>granulomatous inflammation of large vessels</strong>, particularly the aorta and its major branches.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Granulomatous thickening of the vessel wall, often leading to \"pulseless disease\"</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>MPA </strong>is a <strong>type of small-vessel vasculitis </strong>associated with <strong>necrotizing inflammation without granuloma formation</strong>, distinguishing it from the other options that are characterized by <strong>granulomatous inflammation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 513)</strong></span></p>",
    "correct_choice_id": 58708,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14784,
    "choices": [
      {
        "id": 59097,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crohn&rsquo;s disease </span></span></span></p>"
      },
      {
        "id": 59098,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulcerative colitis </span></span></span></p>"
      },
      {
        "id": 59099,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoebiasis </span></span></span></p>"
      },
      {
        "id": 59100,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giardiasis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granulomatous inflammation is found in: </span></span></span></p>",
    "unique_key": "Q1741769",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676702,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Crohn&rsquo;s disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A: </span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Characterized by<strong> granulomatous inflammation</strong>, which is one of the key <strong>histopathological features </strong>that can involve <strong>any segment of the GI tract</strong>. It is known for<strong> transmural inflammation, skip lesions, and granuloma formation.</strong></span></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Ulcerative colitis</strong> is a <strong>chronic inflammatory </strong>condition that affects the<strong> colonic mucosa with continuous lesions</strong>, but without the granulomas typical of Crohn&#39;s disease.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Amoebiasis</strong>, caused by <strong>Entamoeba histolytica</strong>, can result in <strong>ulcerative lesions </strong>within the<strong> GI tract </strong>but does not produce <strong>granulomatous inflammation.</strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Giardiasis</strong>, caused by the protozoan<strong> Giardia lamblia</strong>, typically results in <strong>malabsorption and diarrhea after </strong>affecting the <strong>small intestine</strong>, but without granulomas.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Granulomatous inflammation </strong>is a <strong>specific histopathological finding </strong>that supports the diagnosis of <strong>Crohn&#39;s disease </strong>and is not typically found in <strong>ulcerative colitis, amoebiasis, or giardiasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 801</span></strong></span></span></p>",
    "correct_choice_id": 59097,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14790,
    "choices": [
      {
        "id": 59121,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Majority of patients have associated atopic conditions</span></p>"
      },
      {
        "id": 59122,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Feline esophagus is an endoscopic finding</span></p>"
      },
      {
        "id": 59123,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Treatment of choice is high dose proton pump inhibitors</span></p>"
      },
      {
        "id": 59124,
        "text": "<p><span style=\"font-size:12pt;\">May be associated with food products like cow's milk and soy products</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is incorrect about Eosinophilic esophagitis (EoE)?</span></p>",
    "unique_key": "Q4587339",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676704,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Treatment of choice is high dose proton pump inhibitors</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">The mainstay of<strong> treatment for EoE </strong>involves dietary modifications to<strong> eliminate food allergens </strong>and the use of<strong> topical steroids to reduce eosinophilic inflammation</strong>,<strong> not high-dose PPIs.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.&nbsp;</strong>Patients with<strong> EoE </strong>frequently have <strong>concurrent atopic conditions</strong>, which is a <strong>helpful clue </strong>in the diagnosis of this condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B.&nbsp;Feline esophagus </strong>is a term used to describe the <strong>ringed appearance of the esophagus </strong>seen during endoscopy in patients <strong>with EoE.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.&nbsp;Food allergens such as cow's milk and soy </strong>are often implicated in<strong> EoE</strong>, and dietary elimination of these can be part of the management.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>incorrect statement is (c). </strong>The treatment of choice for <strong>eosinophilic esophagitis is not high-dose proton pump inhibitors </strong>but rather<strong> dietary modifications and steroids.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 760</strong></span></p>",
    "correct_choice_id": 59123,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14762,
    "choices": [
      {
        "id": 59009,
        "text": "<p><span style=\"font-size:12.0pt;\">Myxoma</span></p>"
      },
      {
        "id": 59010,
        "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
      },
      {
        "id": 59011,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibroma</span></p>"
      },
      {
        "id": 59012,
        "text": "<p><span style=\"font-size:12.0pt;\">Leiomyosarcoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Most common primary tumor of heart is which of the following?</span></p>",
    "unique_key": "Q9638328",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676694,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Myxoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most common<strong> primary tumor of the heart is a myxoma</strong>. Myxomas are typically <strong>benign tumors </strong>that most commonly arise in the <strong>atria of the heart</strong>. They are often found in the <strong>left atrium </strong>and can cause symptoms such as <strong>obstruction of blood flow, </strong>leading to issues like <strong>syncope and heart failure</strong>. <strong>Myxomas </strong>are composed of <strong>stellate or plump cells </strong>within a<strong> myxoid stroma</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Myxoma </strong>is indeed the most common<strong> primary tumor of the heart</strong>. These<strong> benign tumors </strong>are often found in the<strong> left atrium </strong>and can cause<strong> obstructive symptoms affecting blood flow</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> <strong>Rhabdomyosarcoma </strong>is a type of <strong>malignant soft tissue tumor </strong>that can occur in the<strong> heart</strong>, but it is not the most common primary cardiac tumor.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Fibroma </strong>is another type of<strong> benign cardiac tumor </strong>that typically occurs in <strong>children</strong>. While it can be found in the heart, it is not as common as myxoma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Leiomyosarcoma </strong>is a <strong>malignant tumor of smooth muscle cells. </strong>It is rare in the heart and is not the most common primary cardiac tumor.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most common <strong>primary tumor of the heart is a myxoma</strong>, which is a<strong> benign growth </strong>that most commonly arises in the <strong>atria, particularly the left atrium</strong>, and can lead to symptoms related to<strong> blood flow obstruction.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><i><strong>&nbsp;(Ref: Robbins 10<sup>th</sup>/579)</strong></i></span></p>",
    "correct_choice_id": 59009,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14751,
    "choices": [
      {
        "id": 58965,
        "text": "<p><span style=\"font-size:12pt;\">Anitschkow cells</span></p>"
      },
      {
        "id": 58966,
        "text": "<p><span style=\"font-size:12pt;\">Epithelioid cells</span></p>"
      },
      {
        "id": 58967,
        "text": "<p><span style=\"font-size:12pt;\">Giant cells</span></p>"
      },
      {
        "id": 58968,
        "text": "<p><span style=\"font-size:12pt;\">Fibrinoid necrosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Aschoff bodies in rheumatic heart disease show all of the following features, except:&nbsp;<i>&nbsp;</i></span></p>",
    "unique_key": "Q6297568",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676689,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. B) Epithelioid cell</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Aschoff bodies </strong>consist of <strong>foci of swollen eosinophilic collagen </strong>surrounded by <strong>lymphocytes (primarily T cells),</strong> occasional <strong>plasma cells, and plump macrophages </strong>called <strong>Anitschkow cells </strong>(<strong>pathognomonic for rheumatic fever)</strong>. These cells are also called <strong>\u201ccaterpillar</strong> <strong>cells\u201d.</strong> Some of the<strong> larger macrophages</strong> become <strong>multinucleated to form Aschoff giant cells.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Epithelioid cells</strong> are characteristic of <strong>granulomatous inflammation</strong>, such as seen in <strong>tuberculosis or sarcoidosis,</strong> not in rheumatic fever.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A:</strong> <strong>Anitschkow cells </strong>are a<strong> hallmark of Aschoff bodies </strong>found in <strong>rheumatic heart disease</strong>. They are<strong> plump macrophages</strong> with a <strong>central round nucleus</strong>, giving a<strong> caterpillar-like appearance</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:</strong> <strong>Giant cells, or Aschoff giant cells, </strong>result from the<strong> fusion </strong>of <strong>macrophages</strong> and are a feature of <strong>Aschoff bodies.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong>&nbsp;<strong>Fibrinoid necrosis</strong> is typically associated with several vasculitis as well as Rheumatic heart disease</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Aschoff bodies</strong>, pathognomonic for <strong>rheumatic fever</strong>, consist of <strong>swollen eosinophilic collagen, T cells, occasional plasma cells,</strong> <strong>Anitschkow cells, and Aschoff giant cells.</strong> <strong>Epithelioid cells </strong>are<strong> not </strong>a feature of <strong>Aschoff bodies</strong> and are instead associated with <strong>granulomatous inflammation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 561)</strong></span></p>",
    "correct_choice_id": 58966,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14727,
    "choices": [
      {
        "id": 58869,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cell arteritis </span></span></p>"
      },
      {
        "id": 58870,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takayasu arteritis </span></span></p>"
      },
      {
        "id": 58871,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Churg-Strauss syndrome </span></span></p>"
      },
      {
        "id": 58872,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyarteritis nodosa </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neutrophilic infiltration with fibrinoid necrosis in walls of vessels is seen in: </span></span></span></p>",
    "unique_key": "Q5603069",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676676,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Polyarteritis nodosa </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neutrophilic infiltration </strong>with <strong>fibrinoid necrosis </strong>in the walls of vessels is a characteristic <strong>histopathological finding in Polyarteritis nodosa </strong>(PAN). <strong>PAN </strong>is a <strong>systemic necrotizing vasculitis </strong>that primarily <strong>affects medium-sized arteries</strong>. The <strong>inflammatory process </strong>in <strong>PAN </strong>involves <strong>neutrophils infiltrating the vessel walls</strong>, leading to <strong>necrosis and damage to the affected arteries</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Giant cell arteritis </strong>is characterized by <strong>granulomatous inflammation </strong>rather than fibrinoid necrosis. It typically involves large to medium-sized arteries.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Takayasu arteritis </strong>involves <strong>large vessels</strong>, often the <strong>aorta and its main branches</strong>. Fibrinoid necrosis is not a prominent feature in Takayasu arteritis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Churg-Strauss syndrome </strong>also known as <strong>eosinophilic granulomatosis with polyangiitis </strong>(EGPA), is characterized by <strong>eosinophilic infiltration </strong>and <strong>granulomatous inflammation</strong>. Fibrinoid necrosis is not a primary histopathological feature.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neutrophilic infiltration </strong>with <strong>fibrinoid necrosis in walls of vessels </strong>is seen in <strong>Polyarteritis Nodosa</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Robbins 10<sup>th</sup>/ 512) </span></span></em></strong></p>",
    "correct_choice_id": 58872,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14855,
    "choices": [
      {
        "id": 59380,
        "text": "<p><span style=\"font-size:12.0pt;\">Bronchial asthma</span></p>"
      },
      {
        "id": 59381,
        "text": "<p><span style=\"font-size:12pt;\">Chronic bronchitis</span></p>"
      },
      {
        "id": 59382,
        "text": "<p><span style=\"font-size:12.0pt;\">Bronchiectasis</span></p>"
      },
      {
        "id": 59383,
        "text": "<p><span style=\"font-size:12.0pt;\">Emphysema</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 45-year-old patient presents with a chronic cough and dyspnea. The sputum analysis reveals the presence of Charcot-Leyden crystals and Curschmann's spirals. Which of the following respiratory conditions is most likely associated with these findings?</span></p>",
    "unique_key": "Q2217568",
    "question_audio": null,
    "question_video": null,
    "map_id": 34676677,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Bronchial asthma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Bronchial asthma </strong>have the sputum findings like <i><strong>Charcot-Leyden crystals&nbsp;</strong></i><strong>(needle-shaped crystals composed of eosinophilic membrane protein) </strong>and <i><strong>Curschmann's spirals&nbsp;</strong></i><strong>(spiral-shaped mucus plugs formed by the shedding of the bronchial mucosa).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Chronic bronchitis </strong>is characterized by<strong> inflammation of the bronchi</strong>, leading to <strong>increased mucus production </strong>and a <strong>persistent cough</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C: Bronchiectasis:</strong> In bronchiectasis, there is <strong>irreversible dilation of the bronchi</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Emphysema </strong>is characterized by the <strong>destruction of alveolar walls and airspace enlargement</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">However,<strong> Charcot-Leyden crystals and Curschmann's spirals </strong>are <strong>not typically </strong>associated with <strong>chronic bronchitis, bronchiectasis and emphysema.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of <strong>Charcot-Leyden crystals and Curschmann's spirals in sputum </strong>is characteristic of <strong>bronchial asthma</strong>, reflecting <strong>eosinophilic inflammation </strong>and <strong>shedding of the bronchial mucosa</strong>, respectively, and are <strong>not </strong>typically found in <strong>chronic bronchitis, bronchiectasis, or emphysema</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 685)&nbsp;</strong></i></span></p>",
    "correct_choice_id": 59380,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00274 Mid Day Module (Pathology-4)';
        const quizFilename = '00274-mid-day-module-pathology-4-96d4e6f7.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>